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                                                                  ABSTRACT 
       
     Background: Adherence of patients on antiretroviral therapy to lifelong treatment is a major 
challenge within the public health system in Namibia. Missed appointments have been shown to 
contribute to poor clinical outcomes and treatment failure, which may necessitate switching to 
more expensive antiretroviral regimens. In resource limited settings monitoring of appointments 
for antiretroviral medication pick up is a documented and feasible method for assessing 
minimum levels of adherence to antiretroviral medication. 
      Aim: This study was aimed at evaluating the effects of telephonic short message service 
reminders influence on adherence to scheduled antiretroviral medication pick up appointments. It 
was also aimed at evaluating how socio-demographic parameters might moderate the 
effectiveness of short message service reminders. 
      Study design: A randomized double blind controlled study design was employed. 
Methodology: Stable patients attending the ART clinic were recruited and randomly assigned to 
either an intervention or control group, until the sample size of 398 was reached in the two arms 
of the study. The study population were adult patients’ ≥ 18 years who have been enrolled on 
treatment for ≥ 3months.  The intervention group received an unasked for single short message 
service reminder, sent 48 hours before their scheduled appointments and continued with standard 
care, while the control group received standard care without any reminder.  The study 
participants were blinded to their study group. Also, research assistants involved in collecting 
baseline and outcome data were blinded to study participants study group. Baseline data was 
collected through a structured questionnaire. Study participants were followed up for four 
consecutive scheduled ARV pick up appointments. The following outcome data were collected 
at each follow up visit; number of days late after scheduled appointment, adherence measured by 
pill count and 3 days self-report recall of adherence. 
      Main results: The pre-intervention survey revealed that only 60% of the study participants were 
willing to be reminded of their medication pick up appointment. Overall, the SMS reminder 
improved adherence to medication pick up appointments by 1.6 times as compared to no 
reminder and also reduced the risk of missing medication pick appointments by 22% as 
compared to no SMS reminder. Study participants that received a reminder were also two times 
more likely to achieve optimal adherence to their medication, compared to those who received 
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no reminder. The SMS reminder improved adherence to antiretroviral medication by 11% in this 
study, while the mean difference in the number of days late to collect antiretroviral medication 
was significantly reduced by about 4 days by the intervention. Participants that are employed 
were more likely to adhere to antiretroviral medications as compared to the unemployed. 
Ironically participants that were on ART for less than one year and those that had treatment 
supporters reminding them of their medication appointments were significantly less likely to 
honour their medication pick up appointments. 
Conclusion: Being employed was significantly associated with attaining optimal adherence to 
antiretroviral medication.There were no other significant associations between the patients socio-
economic and demographic characteristics and adherence to scheduled medication pick up 
appointments, or to adherence to medication.  
Recommendations: The Ministry of Health and Social Services should consider rolling out 
SMS reminders to ART sites with similar settings as Swakopmund State Hospital ART Clinic. 
Patients that are willing to receive the reminder should be targeted in the scaling up of the roll 
out. Late and missed medication pick up appointments could be used as an easy proxy 
measurement for assessing adherence to ART. 
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                                               CHAPTER 1 
INTRODUCTION 
 
1.1 Overview of the HIV/AIDS pandemic 
  
There are 34 million people living with human immune deficiency virus (PLHIV) globally as at 
the end of 2011, with sub-Saharan Africa accounting for 68% of the global human immune 
deficiency virus (HIV) burden. Sub-Saharan Africa carries the greatest burden of the human 
immune deficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) pandemic. In 
2012, 1.8 million new infections and 1.3 million AIDS-related deaths among adults and children 
were recorded in sub-Saharan Africa (UNAIDS, 2012). The benefit of antiretroviral therapy 
(ART) in the reduction of mortality and morbidity rates among PLHIV is a factor that has lead to 
a rapid scale up of ART services globally with the number of people dying from HIV/AIDS 
related causes reported to have declined by 32% from 2005 to 2011. As of the end of 2011, over 
8 million PLHIV were benefitting from ART, thereby enabling more PLHIV to have an 
improved quality of life and be productively engaged in their communities. Results achieved 
from the global response to the HIV/AIDS pandemic inspired the new global target of providing 
ART to 15 million PLHIV by 2015, an indication that HIV care and treatment has evolved from 
an ad hoc emergency response to the point of developing a sustainable program for the varied 
number of people living with HIV (Elul et al., 2011; UNAIDS 2012). As countries plan to scale 
up their ART programs to meet this target, retaining patients on treatment remains a cardinal 
challenge in sustaining the progress made thus far and successfully reaching new targets.  
 
1.2 HIV/AIDS and antiretroviral therapy in Namibia 
 
Namibia has the fourth highest HIV prevalence in Africa with the first HIV case diagnosed in 
1986. Since then the prevalence of HIV has increased from 4.2% in 1992 to 19.9% of adult 
population in the year 2006, based on a report from the sentinel surveillance which also revealed 
a slight drop to 18.8% in 2010 (MoHSS 2010a). Namibia adopted a public health approach to the 
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HIV/AIDS epidemic by ensuring availability of high quality HIV care and treatment for all 
eligible patients, at no cost to patients. In addition, approximately 120,000 HIV tests are 
performed annually in the Voluntary Counseling and Testing (VCT) sites that are available in 
most health facilities and testing sites in the communities all over the country (MoHSS, 2010b; 
MoHSS, 2011c). However patients must meet the WHO clinical staging and social eligibility 
criteria before they are entered into the ART program as stipulated in the National ART 
Guidelines. The clinical criteria are based on the WHO clinical staging of HIV progression in 
patients, while the purpose of the social eligibility criteria is to maximize adherence and to 
reduce the risk of defaulting and ensure patients are retained on the ART program (MoHSS, 
2010a). The social criteria for eligibility into the ART program include the following: 
 Client must have lived at a fixed address for the past three months. 
 He/she must have ready access to a designated treatment center for follow- ups. 
 He/she must have a treatment supporter, preferably a close family member. 
 He/she must have no underlying psychotic illness. 
 He/she must not abuse alcohol or drugs. 
 He/she must be committed to lifelong treatment and the practicing of safe sex. 
 
     Namibia’s ART program is reputed to be one of the success stories among countries affected by 
the HIV pandemic in terms of the provision of ART and the coverage of the people in need of 
ART. There are presently 221 health facilities which includes; 1 referral hospital, 3 intermediate 
hospitals, 34 district hospitals, 68 health centers and clinics and 117 outreach sites that are 
offering ART services to approximately 84% of PLHIV in need of care and treatment.(MoHSS, 
2012 a).The Ministry of Health and Social Services (MoHSS) scaled up the ART program in 
July 2010 by raising the eligibility criteria from less than 200 cells/cubic micro liters (<200 
cells/l3) of CD4 cells to less than 350 cells/cubic liters (<350 cells/l3) (MoHSS, 2010a). As a 
result of the scale up, there was a remarkable increase in the uptake of PLHIV into the ART 
program. At the end of 2012, the number of PLHIV on ART increased by over 100% from 
56,000 recorded in June 2010 to 107,154 at the end of March 2012. (MoHSS, 2012b). As the 
country strives towards achieving its target of 95% ART retention rate, it is important that 
PLHIV are supported in ensuring adherence to their ART regimens (MoHSS, 2012b). 
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1.3 Potential cost of non-adherence to scheduled ARV pick up appointments 
 
 Several studies have documented different reasons reported by patients for missing clinic 
appointments and these include among others forgetfulness, work related issues and travelling as 
the major reasons why PLHIV miss their scheduled clinic appointments. Patients on ART require 
a lifelong commitment and missing scheduled clinic or medication refill  appointments  is a 
likely indicator for dropping out of  care and patients becoming lost-to-follow-up (Horstmann  et 
al., 2010).  
      The economic cost associated with missed appointments in primary care and hospital outpatients 
was estimated to be £360 Million by the National Health Service of England. This estimate was 
based on a 12% national annual rate of non-attendance, with each missed visit estimated  at an 
average cost of £61 in 1997 (Stone et al., 1999). Direct financial cost may not be incurred at the 
Swakopmund ART clinic as a result of missed appointments, because the government offers care 
and treatment at no cost to all PLHIV. However, Murdock et al (2002) reasoned that the 
maximum use of resources and total time spent by patients waiting to be seen are prime 
considerations in missed appointments. In cases where patients do not show up, there is a 
reduction in waiting times, however administrative resources and equipment might be 
underutilized. 
 
1.4 Use of mobile phones in health care delivery  
 
Access to mobile phones in Namibia has increased considerably from the time of the inception of 
the GSM technology in 1999, currently there are two mobile phone networks in Namibia.  
Research ICT Africa in collaboration with the Communication Regulatory Authority of Namibia 
(CRAN) conducted a nationally representative survey from June 2011 to August 2011. The result 
from the survey shows that 56.2% of Namibians owned a mobile phone and of those without 
mobile phones, 41% had used a mobile phone in the past 3 months, while 28% owned an active 
SIM (Subscriber  Identification Module) card (Research ICT Africa, 2011). The report failed to 
differentiate between access to mobile phones in urban and rural areas, it is expected that usage 
of mobile phone will be much higher in urban areas than in the rural areas. The result of this 
survey also indicates a high rate of shared phone usage which makes privacy and confidentiality 
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a major concern, because of the stigma associated with HIV infection.  Other studies  suggests  
that privacy and confidentiality were not deterrents to the use of voice calls and SMSs as 
reminders in a rural setting in Uganda and in Durban an urban setting in South Africa (Kunutsor 
et al., 2010; Crankshaw et al., 2010). 
      Mobile phone is evolving into an integral part of the people’s life, transcending socio economic 
and cultural groups. Business organizations are already taking advantage of the increasing access 
to mobile phones and have used SMS as a form of mass media to promote products and services 
(Cole-Lewis et al., 2010). The Ministry of Health and Social Services (MoHSS) also uses SMS 
to inform and educate the public on issues pertaining to public health, such as national 
immunization and HIV testing campaigns. SMS is also used to educate the public on other issues 
of public health importance. Messages are sent through this medium on designated United 
Nations health days such as cancer and no tobacco days. Integrating telecommunications into the 
health care delivery system is a priority in resource limited settings. (WHO/UNAIDS, 2006). 
Currently, at the Swakopmund ART clinic mobile phone is utilized as a tool to support patients 
on their adherence programs in both HIV and TB programs. Patients who are lost to follow up 
are sometimes tracked by clinic staff through the use of voice calls.  
      The pre-emptive use of SMS appointment reminders in reducing missed scheduled appointments 
and subsequent  reduction in treatment interruption and lost to follow up, holds promising 
results. Preliminary results from the Right to Care Themba Lethu clinic shows that lost to follow 
up rates was reduced to less than 4% with the introduction of automated SMS appointment 
reminders. The system also allowed patients to reschedule their appointments at no extra cost to 
the patient (Maphan, 2008).  
      Therefore the potential of SMS appointment reminders as a health care intervention in an urban 
resource limited public ART program needs further investigation.  
 
1.5 Adherence to scheduled medication pick up appointments at the Swakopmund ART 
Clinic. 
       
      A national survey on adherence to ARV medication refills reported that 84% of patients at the 
Swakopmund ART clinic pick up their medications on time, as compared to the national average 
of which 65% of patients pick up their ARV medications on time. In this survey patients who 
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were late by 1-4 days were considered as being adherent to their ARV refill appointments, 
because it was assumed that patients are routinely given medications to last beyond their 
scheduled appointment dates for refill (Lates et al., 2011). Results from this survey also shows 
that a notable number of patients on ART miss their ARV refill appointments at the 
Swakopmund State Hospital ART Clinic. ARV pick up is one of the early warning indicators 
(EWI) recommended by the World Health Organization (WHO) for use in resource limited 
settings as a minimum strategy for routine monitoring of the emergence of HIV drug resistance 
(HIVDR). Noting that sub-optimal adherence is one of the factors associated with HIVDR, the 
WHO recommended a target greater than 90%  for the percentage of patients picking up all 
ARVs on time, before the previous ARVs prescribed runs out if taken as prescribed  (Hong et al., 
2010).  In another survey conducted at the Swakopmund ART clinic among patients who missed 
their scheduled appointments, Manhando et al. (2011) demonstrated that 12% of those who 
missed their scheduled appointments reported that they interrupted treatment. It is reasonable 
therefore to hypothesize that a significant proportion of the 84% of patient that were late by 1-4 
days in addition to the 16 % that were non adherent to their scheduled ARV refill appointments 
were likely to have interrupted treatment. This evidence provides support to the argument that 
missed appointments is a potential risk factor for treatment interruption, which may increase the 
risk of more opportunistic infections, and increase the rate of treatment failure. Treatment failure 
consequently necessitates patients being switched to more expensive second line antiretroviral at 
the Swakopmund ART Clinic. 
      Although the impact of waiting times on non-adherence to scheduled appointments has not been 
fully evaluated at the Swakopmund ART clinic, one of the major complaints expressed by 
patients from the suggestion box in the clinic, which is reviewed bimonthly during the ART 
clinic meeting, was the unduly long waiting times at the pharmacy (Personal Interview, Dr. 
Manhando Medical Officer in charge of the clinic). Indeed waiting times have been identified 
and reported as a major source of demotivation for keeping scheduled ARV appointments. 
(Hardon et al., 2006: Nelson, 2012). When patients do not honour their scheduled appointment   
for ARV medication refill, the equilibrium in the number of patients expected in the different 
days of the month is distorted. This may be a major reason for longer waiting times on some 
days when many patients do arrive, whilst at other times sub-optimal use of administrative and 
human resources has resulted from non-adherence to scheduled appointments.  
 
 
 
 
6 
      The Swakopmund ART Clinic reported a rapid remarkable increase in the number of patients on 
ART, with the number of patients on ART reported to have increased by over 120% from 800 
patients enrolled in June 2008 to over 2,350 reported in June 2011. The staff complement in the 
pharmacy has not changed in the past 4 years (Niaz and Ongeri, 2011).  Mc Coy et al. (2005) 
identifies weak adherence support as one of the pitfalls that is associated with the rapid scale up 
of ART in developing countries, with limited resources and inadequate health infrastructure. 
Furthermore an increase in health care provider frustration and decrease in patient-provider 
communication, which may complicate adherence to ART are also consequences of missed 
appointments (Horstmann et al., 2010). 
 
1.6 Description of the study setting 
 
This study was conducted at the Swakopmund State Hospital ART Clinic in Swakopmund, a 
district in the Erongo region of Namibia. Swakopmund is an urban cosmopolitan town, its 
economy thrives on a booming tourism, mining and construction industries. Because of its 
growing economy, skilled and semi-skilled migrants from other regions are attracted to the town 
(Siapac & JTK, 2002). According to the 2011 census report, a population of 44,700 out of the 
country’s estimated total population of 2.1 million resides in the Swakopmund district (National 
Population Commission, 2012). 
      Swakopmund district recorded a HIV prevalence rate of 17.7% from the 2010 ante natal clinic 
sentinel surveillance survey, which is slightly lower than the 18.8 % national average (MoHSS, 
2010). Swakopmund ART Clinic is one of the other 34 ART sites providing full ART services to 
Namibians. The clinic is located within the Swakopmund State Hospital and it is the only public 
secondary level health facility providing preventive and curative health services to the residents 
of Swakopmund and surrounding settlements in addition to some private clinics also providing 
ART services to a limited number of paying clients or patients on medical aid (Medical 
Insurance) schemes. 
  The ART clinic provides comprehensive HIV care and treatment services, voluntary counseling 
and testing for HIV (VCT), nutritional assessment, alcohol screening, screening and treatment of 
sexually transmitted infections, family planning services, clinical investigations, voluntary 
medical male circumcision and linkage to social support services. The clinic also manages and 
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treats all HIV infected patients who have opportunistic infections and or other chronic non 
communicable diseases. Patients that require to be closely observed are admitted as in-patients in 
the hospital, while those that require more specialized management are referred to the referral 
hospital in Windhoek. As of December 2012, the clinic provides care and treatment to about 
4,500 HIV positive patients out of which about 2,500 are on HAART (Manhando, 2010). 
       The Swakopmund ART clinic is staffed by three medical officers, one pharmacist and three 
pharmacists’ assistants, five nurses, two ART data clerks and eight community counselors. 
      The patients’ enrollment on ART program at Swakopmund ART Clinic averages 30 patients per 
month (MoHSS, 2008a). Enrollment of patients into the ART program in the Swakopmund ART 
Clinic is based on the ART national guidelines. The community counsellors routinely offer 
adherence counseling to all  pre-ART clients before they are enrolled on ART, while patients on 
ART are only counselled  when  adherence issues are suspected or when patients are being 
switched to second line ARVs. In order to ensure that those in need of ART services in 
Swakopmund District have equitable access to ART services, a team comprising of a doctor and 
a pharmacy staff embarks on a monthly outreach service to Arandis and Henties Bay located  
60km and 75km respectively away from Swakopmund.  At the Swakopmund Hospital ART 
clinic, multiple appointments are scheduled over time for patients follow up, these appointments 
are medical, laboratory screening visits and ARV refill appointments. Medical appointments may 
vary from monthly to quarterly medical review visits depending on the national treatment 
guideline and the individual patients’ clinical condition, as determined by the medical or nursing 
staff. However, appointments for ARV refills are more regular and are often monthly or bi 
monthly, moreover patients in their first 6 months on ART have up to five ARV pick up 
appointments. Subsequent ARV medication pick up appointments are scheduled bimonthly for 
stable patients reporting good adherence, according to pharmacy refill records and monthly for 
poorly adhering patients as indicated by their pharmacy refill records. Patients are allowed to 
negotiate suitable days for scheduling their ARV medication refill appointments.  
      The pharmacy dispensing staff sees an average of 80 patients per day; this includes patients on 
scheduled appointments, pre-ART patients on routine visits and walk in or sick visits. 
Appointments are scheduled in order to ensure a uniform spread in the number of patients 
attended to all through the working days of the month.  
     The medication refill appointment date is communicated to the patient and is recorded on the 
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patient’s health passport. The health passport is a booklet issued to all patients, in this booklet are 
all of the patients medical history, interventions and prescriptions recorded.  
      One of the measures put in place by the MoHSS to further ensure adherence, is the concept of 
treatment supporters. A treatment supporter is someone who could either be a relative, friend or 
spouse to whom a patient voluntarily discloses his/her HIV status, for the purpose of supporting 
the patient with his therapy. Having a treatment supporter is one of the social eligibility criteria 
for initiating ART (MoHSS, 2010). One of the roles of the treatment supporter among others is 
in reminding the patient of their clinic and medication pick up appointments. 
 
1.7 Problem statement 
      
      A notable proportion of patients miss their scheduled ARV refill appointments at the 
Swakopmund Antiretroviral Clinic. Missing scheduled ARV refill appointments is a risk factor 
for poor clinical outcomes, treatment failure and switching to more expensive ARV regimens. 
Given that over 12% of patients who missed their scheduled ARV refill appointments at the 
clinic reported that they interrupted treatment and as the number of patients on ARV and mobile 
phone usage continue to increase, there is an opportunity to investigate the influence of SMS 
reminders on non-adherence to scheduled ARV medication pick up appointments, at the 
Swakopmund ART clinic. 
 
1.8 Purpose of study 
      
      This study will add to the body of evidence on the effectiveness of the use of mobile technology 
as a healthcare intervention in an urban public ART care and treatment program. The results 
could be used to assist policy formulation around implementation of interventions to improve 
adherence to scheduled ARV medication refill appointments, as well as adherence to 
antiretroviral medication. 
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1.9 Aim 
 
To determine the effectiveness of motivational telephonic Short Message Service (SMS)  
      reminders in enhancing adherence to scheduled medication pick up appointments of patients on 
ART.  
 
1.10 Objectives 
 
 To evaluate the effectiveness of SMS reminders in improving short term adherence to 
scheduled medication refill appointments and adherence to taking medication. 
 To assess the association between adherence to scheduled appointments and adherence to 
medications. 
 To evaluate the influence of the following moderator variables - age, sex, marital status, type 
of employment, treatment supporter and income on SMS reminders and adherence to 
scheduled ARV pick up appointments. 
 To determine the association between SMS reminders and the number of missed days before 
honouring appointments. 
 
1.11 Hypothesis 
 
The use of motivational (SMS) reminders will improve adherence to scheduled medication pick 
up appointments and adherence to the taking of medication, by patients at the Swakopmund ART 
Clinic. 
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                                              CHAPTER 2 
LITERATURE REVIEW 
 
2.1 Introduction 
 
This chapter describes key concepts of this study, namely adherence to ART, as well as the 
advantages and drawbacks associated with different method of assessing and monitoring 
adherence. The use of clinic appointments as a means of assessing and monitoring adherence is 
highlighted. In this chapter, the reasons why HIV patients on ARV miss their clinic appointments 
are also explored. Literatures that describe the potential use of SMS as a reminder and 
demonstrated the effectiveness of SMS reminder in enhancing adherence to ART are presented 
in this chapter. 
 
2.2 Adherence in antiretroviral therapy 
      
       Bangsberg and Deeks (2002) identified poor or sub-optimal adherence as a major reason for 
failure of potentially effective ART. It is important to note that a near perfect adherence to ART 
is required in order to prevent the emergence and development of viral strains that are drug 
resistant, which further limits the number of regimens available to patients. The HIV virus 
replicates at a very high rate, therefore maintenance of viral suppression requires maximum 
patient adherence (Chesney, 2001).  
      It is undoubted that poor or sub-optimal adherence to ART also leads to an increase in health 
cost, which is detrimental to a resource limited setting, because the second line antiretrovirals 
reserved for patients who fail on first lines are generally more expensive, with an additional cost 
of laboratory tests required to be factored in as well (Chesney et al., 2001). 
      Several barriers to optimal adherence to ART has been identified and reported, they are namely  
stigma and discrimination associated with HIV, the debilitating side effects of some HIV 
medicines, long waiting times at the clinic, as well as  high pill burden (Potchoo et al., 2010;  
Elul et al., 2011; Hardon et al., 2006; Nelson, 2012).  
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2.3 Assessing and monitoring adherence 
       
      There is presently no gold standard in assessing HIV adherence with precision and accuracy, 
studies have reported on self-reports, pill count, pharmacy refill records, adherence to scheduled, 
clinic appointments and the monitoring of clinical markers as different measures of adherence 
with their short coming and  diverse degree of accuracy(Population council, 2004). 
Self –report 
      This is one of the routine methods of assessing and monitoring adherence in the Namibian ART 
program. Self-report as a measure of adherence which entails asking patients to report on how 
many doses they have taken or forgotten to take over a given period of time. The duration may 
vary from 3 days to 30 days. According to Population Council, this method is cost effective and 
flexible in design. Furthermore data on the reasons why doses were missed could be collected at 
the same time. Notable challenges associated with self-report include the tendency of patients to 
overestimate adherence. (APHA, 2004; Population Council, 2004). 
Pill counting 
      At most health facilities offering ART services in Namibia, health care providers routinely 
conduct pill counts during scheduled clinic visits to ascertain patient adherence (APHA, 2004). 
Pill counts offers an estimate of the total quantity of doses consumed, usually between clinic or 
ARV refill  scheduled appointments This method though subjective, it has been found to be cost 
effective and practicable in resource limited settings. In settings where mutual trust exists 
between health care provider and patients it offers a good measure of adherence. Pill dumping is 
one of the shortcomings associated with pill counting; firstly, a major drawback with pill count is 
that patients may manipulate their adherence score by dumping pills prior to their clinic 
appointments, thereby leading to an overestimate of their adherence score. Secondly, patients 
may intentionally leave their left over or missed pills at home making it difficult for the health 
care provider to assess adherence. Thirdly, pill count may deter the development of mutual trust 
between health care provider and the patient, because some patients may erroneously assume   
their health care provider do not trust them. (Population Council, 2004). 
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Electronic devices 
      Medical events monitoring system (MEMS), is an electronic system connected to the caps of the 
medicine such that the system records every time the cap is opened, the  computer chips 
connected to the caps records the date and time of opening and closing of medication bottle. 
(Population Council, 2004). The data is interpreted with the assumption that a single dose is 
taken each time the bottle is opened and closed.  Studies have found adherence measured using 
MEMS correlate fairly well with medication intake. 
Pharmacy refill monitoring  
      Kunutsor et al. (2010) reported that the monitoring of scheduled clinic appointments using 
medication refills record is a feasible, practical and reliable method for monitoring and assessing 
adherence to ART in a resource limited setting. Pharmacy staff plays a key role in supporting 
adherence to medication by assessing and monitoring patients’ adherence using pharmacy refill 
data (Population Council, 2004). Monitoring how patients adhere to scheduled medication refill 
appointments can also be used for routine adherence assessment, assuming that patients 
appointments are scheduled in such a manner that the patient is given just enough ARVs to last 
up to the next medication refill appointment, hence failure to honour an appointment could be an 
indication of sub-optimal medication adherence (Farley et al., 2009; Talam et al., 2008; Brenan 
et al., 2010). The disadvantages associated with pharmacy refill monitoring is that, it is not a 
measure of intake of medication, whereby patients who honour all their scheduled appointments 
may not necessarily take all their medicines. 
Biological markers 
      Clinical investigations such as decrease in viral load and increase in the CD4 counts of patient on 
ART have the potential to give an indication of possible adherence to ART (Population Council, 
2004). Since the goal of ART is to lower the plasma viral load, the monitoring of viral load can 
therefore be used as an indicator of adherence to ART. The drawback with this method is that 
viral load monitoring is very expensive and may not be available in resource-constrained 
settings. Viral load assessment as a means of routine adherence monitoring is not sustainable in 
resource poor settings. In the 2003 World Health Organization (WHO) ART guidelines, the 
routine measurement of viral loads was not recommended in resource limited countries. 
However, viral load is routinely done in most high income countries. The cost of a single viral 
load test is  estimated at  $20 - $160 (in US dollar) and the additional   constraints  of  inadequate  
 
 
 
 
13 
equipment and  technical expertise  make  viral load assessment for routine adherence 
monitoring  unsustainable in resource poor settings (Calmy et al., 2006). 
Therapeutic drug monitoring  
      Measuring of therapeutic drug levels in the plasma could detect only recent adherence behavior, 
thus therapeutic drug levels were not necessarily indicative of good adherence (Desai et al., 
2003). Hugen et al. (2002) also noted that low concentrations of antiretrovirals may be caused by 
factors other than adherence, such as mal-absorption, drug interactions, and individual metabolic 
differences. In clinical settings drug monitoring as a means of monitoring is expensive and it is 
not a cost effective and sustainable measure of adherence.   
      In summary, the use of more than one strategy such as self-reports, pill count and adherence to 
scheduled clinic appointments would enhance the accuracy of measuring ART adherence as 
recommended by the WHO (WHO, 2003). 
 
2.4 The importance of appointment keeping and adherence assessment  
 
Good adherence as defined by Muyigo et al. (2008) is not limited to compliance with medication 
but it also includes adhering to all medical and non-medical instructions including keeping 
scheduled appointments. Moreover adherence to appointments has been reported as a useful 
proxy for medication adherence in a HIV care and treatment setting (Talam et al., 2008).  In a 
cross sectional study embedded within a larger clinical trial, Ogedengbe et al. (2003) studied the 
appointment keeping behavior and adherence in hypertensive African Americans. This research 
concluded that appointment keeping does not have any relationship with medication adherence. 
This result detracts from the following studies,  (Farley et al., 2003; Park et al., 2007; Fonq et al.,  
2008; Kunutsor et al.,  2010;  Talam  et al., 2008),  in which  appointment keeping  to scheduled  
appointments had some correlation  with  adherence to medication  and this was associated with 
negative clinical  outcomes  such as poor virological response and immunological failure.  
      Farley et al. (2003), assessed  the  medication event monitoring  system (MEMS) in measuring  
adherence in HIV infected children  and compared this to other  methods of assessing adherence  
Their findings suggest that appointment keeping  records  which are  routinely kept and  
pharmacy refill rates were found to be associated with virological response,  although this was 
not statistically significant,  due to the small sample size, it was clinically significant because the 
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highest specificity were obtained when MEMS and pharmacy refills were combined in the 
adherence measurement. 
      Park et al. (2007), reported a strong association between adherence to clinic visits after initiation 
of ART and later disease progression, in an observational cohort study, aimed at determining 
whether adherence to clinic visits after initiation of ART was predictive of long term clinical 
outcomes. The results indicate that adherence to clinic visits is an independent predictor of long 
term clinical progression to AIDS. They concluded that adherence to clinic visits  may therefore  
be associated with adherence to ARV medicines, as taking ARVs is the only proven way to delay 
progression to AIDS, however, this paper did not differentiate  medication  refill visits  from  
medical visits.  
      On their part Brenan and colleagues (2010), differentiated medication refill visits from medical 
visits in a retrospective cohort study at the Thembu Lethu Clinic Johannesburg in which they 
attempted to quantify outcomes from missing scheduled appointments in the first 6 months of 
initiating ART.  Results from an adjusted multivariate cox proportional hazards analysis showed 
that generally more missed visits were associated with a higher risk of mortality and lost to 
follow up. They reported that missing 2 to 3 medical appointments increased the risk 2 - 4 fold 
while missing ≥ 3 ARV pick up appointments increased the risk 4 - 8 fold (HR 8.2 CI 2.0-33.7). 
This suggest the importance of  adherence to scheduled clinic and medication refill  
appointments  needs  to be emphasized to patients very early during  initiation of ART.  
       Fonq et al. (2008), in a retrospective study by self-report among Chinese  HIV infected patients 
demonstrated that missing clinic appointments was independently associated with partial 
medicine adherence. Adherence was determined by  the ratio of  the  number of missed doses 
since last follow up, adherence  of 100 % was defined as full adherence , while 90 -99 % was 
defined as partial adherence. Their definition of full adherence is high as compared to other 
studies which set optimal adherence at ≥ 95%. 
      Kunutsor et al. (2010) followed up a cohort of patients on ART in an urban hospital in central 
Uganda for 28 weeks. They demonstrated that 31/392 (7.9%) of clients whose clinic attendance 
for refills was not consistent achieved sub-optimal adherence < 95% determined through pill 
count. The association between ARV refills and adherence to medication was found to be 
significant. 
      It is important to note that adherence in HIV care is more complex than the management of non-
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communicable diseases such as diabetes and hypertension. It has been reported that 
stigmatization and discrimination of people living with HIV (PLHIV) further complicates 
adherence in HIV care, while hypertension and diabetes are perceived as elitist diseases in some 
communities (Aikins et al., 2010). PLHIV are expected to strive for 100% adherence, compared 
to the adherence definition of success, which is 80% for other illnesses (Murphy, 2002). The 
current recommendation for ART in HIV infected adults from the International AIDS Society 
USA Panel, recommends regular assessment of adherence with at least 95% needed for best 
outcomes (Murphy et al., 2002).  Good adherence to ART results in undetectable viral load, 
while intermittent therapy and poor adherence to ARV medication causes sub-optimal drug 
levels, which causes natural selection of resistant mutant strains of the virus. Studies have 
demonstrated the inability to suppress viral replication resulting in the development of resistance 
which occurs at adherence levels as high as 92% (Bangsberg et al., 2003). 
      Adherence to clinic appointments and punctual collection of antiretroviral medication are good 
indicators of adherence to ART. A patient who does not keep scheduled appointments is likely to 
indicate poor or sub-optimal adherence because patients are generally given just enough 
medicines up until the next appointment date. Kunutsor et al. (2010) in a cohort study 
prospectively followed up 392 patients  for 24 weeks and the result showed that clinic attendance 
for refills were statistically significantly associated with medication adherence (OR 3.89  
P=0.013)  .   
      On their part, Farley et al, (2003) assessed adherence among pediatric HIV positive patients. 
They compared different methods of adherence assessment namely MEMS, pharmacy refill, 
caregiver self-report in HIV infected children and the results correlated good appointment 
keeping with MEMS adherence rate ≥ 80% (65%) while 6 out of the 9 children that missed 
appointments had a MEMS adherence rate of ≤ 80%. The authors found this association 
clinically significant, even though the sample size was a limitation. 
      Oyugi et al. (2004) assessed and found correspondence between unannounced home pill counts, 
3-day self-report, MEMS and 30 day visual analogue scale measurements. They found all 
measures of adherence to be closely correlated with each other and they also reported a 
significant association with the viral load levels. At twelve-weeks viral load was significantly 
associated with all adherence measures (MEMS, R= −0.34, P= 0.04; pill count, R=−0.41, P= 
0.01; visual analog scale, R = −0.36, P= 0.03; and 3-day self-report, R= −0.42, P= 0.01). 
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Appointment keeping can therefore be used in combination with self-report and pill counts in 
assessing patients’ adherence to antiretroviral therapy.  
     
2.5 Reasons why HIV patients miss scheduled clinic appointments 
 
An understanding of the reasons behind non-adherence to scheduled appointments by HIV 
infected patients on ART will give an indication of the potential benefit of introducing SMS 
reminders as an intervention to improve adherence. 
      Indeed an unpublished self-report survey, reported on the reasons why patients on ART missed 
their scheduled appointment at the Swakopmund Hospital ART Clinic.  The different reasons for 
missing appointments ranged from work related 29 (17.3%), forgetting 20 (11.9%) to transport 
issues, 60 (35.4%) (Manhando et al., 2011). 
      A similar pilot study, using self-report was carried out in Hong Kong by Park et al. (2007), in 
which HIV infected patients were prospectively monitored. The study indicated work issues 22 
(36%) and forgetting, 13 (21%) as the major reasons for missing scheduled clinic appointments. 
      On the other hand Potchoo et al. (2010), in a cross sectional exploratory study conducted in 
Togo, West Africa, sought to identify factors related to non-adherence to HAART in 43 adult 
patients who missed at least one dose of their treatment. The study established forgetting 34.9%, 
travel 25.6%, and cost of treatment 13.9% as reasons for non-adherence. 
      Obviously, a significant percentage of patients in all 3 studies reviewed reported forgetfulness or 
forgetting and travelling issues as reasons for missing scheduled appointments. These results 
suggest a potential benefit from using SMS reminders in HIV infected patients on ART. The 
individual social demographic state of patients such as age, gender, and education might 
significantly affect their ability to consistently adhere to clinic appointments. Kunutsor et al. 
(2010) prospectively monitored a 2,267 cohort of HIV positive patients over a 28-week period in 
a District hospital in Uganda. They reported a significant association between patients whose 
adherence to clinic appointments were irregular and those with no education. In this study 
irregular appointment was defined as failure to achieve > 90% of total clinic appointments within 
a 28-week period. Also patients of 35 years and below were significantly less likely to achieve 
regular attendance.   
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2.6 Potential use of SMS in improving adherence to clinic appointments       
       
      Information technology has immense potential in facilitating and resolving development 
problems.  However, the effectiveness of mobile phone technology as a health care delivery 
intervention has not been fully studied in resource-limited settings. 
      While some studies and reviews support the mobile phone intervention as a cost effective 
intervention to improve adherence in chronic disease conditions, other recent reviews suggest 
otherwise.  Kaplan, (2006) systematic review shows conflicting reports both in support and in 
validation of the cost effectiveness of both fixed and mobile phones as devices for health care 
intervention, this conclusion drawn from the review may be due to the fact that the review 
sampled various kinds of health care interventions such as the use of communication technology 
in health information and in non-communicable diseases. Moreover the majority of the papers 
reviewed were not specifically related to adherence in HIV care. Furthermore some of the papers 
reviewed were pilot studies and the authors did not report on the sample sizes. The review 
provided weak evidence upon which a policy could be developed especially as it relates to 
resource limited settings, because out of 43 studies reviewed, 41 of the studies were from 
developed countries. The authors therefore proposed more well designed randomized trials in 
determining the efficacy of telephone technology as a cost effective health care intervention. 
     The rationale for scheduling patients’ appointments is to ensure human and administrative 
resources are optimally utilized. Hasvold and Wooten (2011) noted that patients that fail to 
report for their scheduled appointments add to inefficiency in the use of resources. They 
conducted a systematic review of studies providing reminders as a health care intervention. The 
review considered manual phone calls, short message services (SMSs) and automated phone call 
reminders in the review. A total of 33 studies were included in the review, out of which 9 of the 
studies were RCTs and the other study designs were before – after interventions, non-
randomized controlled trials, retrospective and prospective cohorts. The sample size of the 
studies reviewed ranged from 100 – 16,400, the median of the duration of the intervention was 3 
months while 2.75 days was the median of the number of days between when the intervention 
was delivered and the scheduled appointment day. The result from this systematic review shows 
that there was a reduction in the rate of non-adherence to scheduled appointments in all but one 
of the studies. A mean relative risk reduction of non-adherence to schedule appointment of 39% 
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was reported in phone and SMS reminders compared to 29% of relative risk reduction among the 
automated reminder group, this suggests that a health worker operated reminder message might 
be less intrusive and therefore more effective than an automated reminder system. The dates and 
times the automated voice calls and SMSs were delivered are computer programmed. They 
found no significant effect between when the reminder was sent relative to the appointment date. 
It is important to note that the authors did not carry out a meta-analysis because of the 
heterogeneity of the studies reviewed, therefore caution should be applied in interpreting and 
generalizing outcomes from the study, and most importantly none of the studies reviewed were 
conducted in sub-Saharan Africa.   
      Crankshaw et al. (2008) explored the patterns of use and the feasibility of using cellular phones 
for clinic appointment reminders and adherence messages in an antiretroviral treatment clinic. 
This study was conducted in Durban, an urban setting in South Africa. Results indicate that 99% 
of patients were willing to receive reminder voice messages, while 98% of patients were willing 
to receive SMS as reminders of their appointment. Their findings confirm a higher access and 
use of mobile phones as expected in an urban setting.  
      Relatively high mobile phone access and ownership has been reported in a rural setting.  Shet et 
al. (2010) reported a 74% ownership out of which 26% were shared ownership in rural Southern 
India, in an exploratory pilot study with the aim of designing mobile phone interventions that 
will enhance adherence to antiretroviral medication. They reported that 66% of the patients 
sampled were already using mobile phones to contact their health care provider and that 
confidentiality and privacy was not a deterrent factor in this setting. The authors concluded that 
mobile phones have the potential to enhance adherence in HIV care and management. 
      In the same vein Puccio et al. (2006) in a pilot program studied the use of cell phone reminder 
calls for assisting HIV infected adolescents and young adults to adhere to ART.   Participants 
received free cell phones, with 250 free local “anytime” calls including weekends, furthermore 
participants received 10 USD for completing each questionnaire and the report did not indicate 
that the cell phones were taken back from the study participants at the conclusion of the study. In 
the first 4 weeks, daily calls were made to participants, after which the calls were tapered, with 
calls occurring from Monday through Friday from week  5- 8 and from week 9 – 12 , calls 
occurred on Sunday, Tuesday and Thursday. Subjects were allowed to choose their preferred 
time to receive calls and depending on the medication regimen, calls could either be once or 
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twice daily. The results from this study  demonstrated that  most of the participants found calls to 
be helpful and the intrusion into their daily lives acceptable, they also reported a significant 
decrease in viral load which they attributed to adherence call reminders, although the authors  
acknowledged the limitation of the small sample size which is expected in a pilot study.  
 
2.7 Testing the effectiveness of SMS reminders in improving adherence  
  
In the review of literature, some studies have tested effectiveness of SMS reminders in 
improving adherence to clinic attendance in general outpatient departments and in primary care 
settings for various disease conditions. 
      In an observational study carried out in an ophthalmology outpatient in London, Koshy et al. 
(2008) reported a 38%  decrease in  non - attendance rate  amongst  patients that received SMS 
reminders compared to those that were not reminded. They concluded that SMS reminder is a 
cost effective way of improving adherence to clinic appointments. Similar results were reported 
by Hogan et al. (2009) in a Urology outpatient department. The high rate of non – attendance 
noted in the department informed the survey on the potential impact of SMS reminders on non – 
attendance rate. SMS reminders were sent 3 days prior to the scheduled appointment. In the two 
years prior to the introduction of the intervention they reported a 17.6% (4,544 patients) non – 
attendance rate, but after the introduction of SMS reminders the non – attendance rate declined to 
12.4% (3,423 patients). The authors concluded that the SMS reminders influenced by about 50% 
adherence to scheduled clinic appointments. However, this result cannot be generalized because 
factors that lead to adherence in HIV care and management are more complex than in conditions 
presenting at a urology general outpatient department. In HIV care adherence is influenced by a 
complex interaction of patient, medicine and virus related factors, moreover PLHIV are expected 
to adhere to treatment throughout their life time. (Chesney, 2001; Farley et al., 2003). 
      Kunutsor et al. (2010) in a cross- sectional prospective study conducted in Uganda studied the 
use of mobile phones in improving clinic attendance in a rural setting. Study participants who 
owned mobile phones were immediately called or sent SMS reminders based on their preference 
as soon as they missed their scheduled appointments. The result indicated that 177(64%) had 
access to mobile phones, which is relatively high for a rural setting. A total of 176 clinic 
attendees for medication refills were monitored prospectively for 28 weeks. The total number of 
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scheduled appointments recorded was 560, out of which 477 were on scheduled visits, while 62 
(11% of appointments) were missed visits. Among the group that missed their visits, 49 (79%) of 
those who received reminders presented for treatment within 2.2 days. Despite the mobile phone 
intervention, 9 scheduled appointments were still missed. Adherence levels were assessed using 
routine clinic based pill count before and after the mobile phone intervention. They reported 
adherence levels to be significantly higher during the mobile phone intervention.  This sampling 
procedure gives room for selection bias because it is likely that a cohort of more motivated and 
adhering patients were enrolled into the study. The effectiveness of the reminders cannot be 
validly evaluated in the absence of controls and the effect of confounders was not analyzed, they 
could therefore not conclude that the improvement in appointment adherence could solely be 
attributed to the introduction of the intervention. 
      Appointment reminders can be delivered through different means asserts Perron et al. (2010) in a 
randomized control trial, designed to test the effectiveness of sequentially delivered reminders in 
reducing the rate of missed appointments at an urban primary health care clinic in Geneva. Study 
participants were randomized into two groups, the control did not receive any intervention, while 
the intervention arm were sent reminders sequentially, firstly by phone call, followed by a simple 
SMS indicating date of appointment and name of medical officer, and a postal reminder which is 
sent 48 hours  prior to the appointment date , which is received the next day. Analysis of the 
results shows that the two groups were balanced and the overall intervention significantly 
reduced the rate of missed appointments from 11.4% in the control group to 7.8% in the 
intervention arm. However, in the HIV and Dietician clinic the rate of missed appointment 
reduction was not statistically  significant p=0.62 and 0.75 respectively, while the  other clinics 
such as general outpatients and  smoking cessation clinics reported significant reductions  in 
missed appointments. They reported that being in the arm of the intervention decreased the odds 
of missing an appointment in all categories of patients (OR 0.63 95% cl 0.43- 0.89). The report 
also revealed that being young, male, asylum seeking and being cared for by a junior doctor 
rather than a senior doctor and having substance abuse problems were significantly associated 
with missed appointments. In a poor or resource limited setting delivering reminders sequentially 
as reported may not be practicable and cost effective. In resource limited settings the level of 
missed scheduled appointments may be higher than expected in a developed country.  
      Noting that sequential reminders may not be a cost effective and realistic intervention in a 
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resource limited setting, Chen and colleagues (2010) compared the efficacy of SMS and phone 
reminders in improving attendance at a health promotion centre within the university hospital in 
China. A total of 1,891 participants were randomly assigned into 3 groups, the first group 
received SMS reminders and the second group received phone reminders, while the control 
group did not get any intervention. The study participants were followed up for 2 months and 
results showed that SMS and phone reminders attendance rate  87.5% and 88.3% respectively 
were significantly higher than that of the controls 80.5%. The difference in attendance rate 
between SMS and phone reminders was not statistically significant. They found SMS to be more 
cost effective than phone reminders. This study was conducted in a setting of a high socio 
economic class, the majority of who were living within the university community, which may 
partly explain the high rate of adherence to appointments, reported.  
      The use of SMS reminders in improving adherence to scheduled  appointments,  because of its 
ability to reach large numbers of patients at a relatively lower cost and being less intrusive and  
more discreet, makes it a better option in an urban resource limited setting with a high mobile 
phone ownership rate.(Mapham, 2008)  
      On the other hand Pop-Ellechas et al. (2011) tested the efficacy of a SMS as a reminder in 
adherence to ART in a rural clinic in Kenya. They used a randomized control study design in 
which a total of 431 patients were randomly assigned to control and four intervention groups. 
The intervention groups received long daily SMS reminders, long weekly SMS reminders, short 
daily SMS reminders and short weekly SMS reminders. The SMS messages were chosen to 
address forgetfulness and lack of social support which are barriers to adherence. The short SMS 
messages is simply “This is your reminder”, is aimed at addressing forgetfulness. On the other 
hand, the long reminder which states “This is your reminder be strong and be courageous, we 
care about you”, was designed to address lack of social support and forgetfulness. The study 
participants were followed up for between 12 weeks to 48 weeks. Adherence was monitored 
using (MEMS). The results showed that weekly SMS reminders increased the percentage of 
participants achieving ≥ 90% adherence by 13-16% compared with the controls. A notable 
reduction in frequency of treatment interruption which is a risk factor for development of 
antiretroviral resistance and treatment failure was also reported. It is interesting to note that long 
text weekly reminders was not more effective than the short message weekly SMS. Furthermore, 
daily SMS did not improve attendance rate, whereas 53% of participants who received weekly 
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short SMS reminders achieved 90% adherence compared to 40% scored by the control p=0.03. 
The authors noted that daily reminders might have been too intrusive and diminishing response 
may be responsible for its ineffectiveness in improving adherence. With regards to message 
content, what best influence change in behaviour has not been fully investigated. Weekly short 
SMS reminders is likely to improve adherence to clinic appointments, a significant association 
was reported between adherence to clinic visit and adherence to medication (Talam et al., 2008). 
The frequency of the appointments also affects adherence to scheduled appointments. 
      This is an ideal study design to test the efficacy of SMS reminders on adherence to antiretroviral, 
however the use of MEMS for routine adherence monitoring is not feasible in a resource limited 
setting.  
 
2.8 Summary 
       
      Considering the fact that there is no gold standard for assessing HIV adherence with precision 
and accuracy, literature reviewed shows that self-reports, pill count, pharmacy refill records, and 
adherence to scheduled clinic appointments have been used with different degrees of accuracy. 
Noting that adherence to scheduled clinic appointments has been reported as a useful proxy for 
medication adherence in an HIV care and treatment setting, it is therefore a cost effective option 
for monitoring adherence in a resource limited setting. In addition, several studies recognized 
forgetting as a major reason for patients missing their scheduled clinic appointments; 
consequently the use of SMS reminders has the potential to enhance adherence to scheduled 
appointments in a resource limited setting. 
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                                                CHAPTER 3 
METHODOLOGY 
3.1 Introduction 
 
This chapter details the study design and sampling procedure. The study setting and the inclusion 
criteria as well as the exclusion criteria are also presented in this section. The data collection 
tools and the steps taken to improve the rigor of the study are also described in this chapter. 
 
3.2 Study design 
       
      A quantitative, experimental design sometimes referred to as an interventional study design was 
adopted in determining effects of telephonic SMS reminders influence in enhancing adherence to 
scheduled medication pick up appointments. This design is analytical and is best suited to 
evaluate an intervention. There are different variants of intervention studies which includes 
randomized control trials (RCT), quasi-experimental studies, before – after studies.  A before – 
after study requires baseline data, and in the absence of baseline data, doing a baseline will 
prolong the time required to conclude this study. In a quasi- experimental design one of the three 
essential elements is absent. The RCT study design which is considered as the gold standard of 
intervention studies was adopted in this study. The three essential elements of experimental 
design; intervention, control and randomization were employed in this study. An  RCT is 
regarded as providing  the highest proof of causality and  the  effect of selection  bias and 
confounding which occurs in cross sectional designs and  case control studies are largely 
eliminated  in RCT’s  through experimental  control  measures and randomization. 
      This is a one centre, parallel group, double blinded and randomized controlled trial, in which 
study participants were randomized into 2 groups. 
 
3.3 Study population 
      
      The study participants were recruited from all enrolled adult (≥ 18 years) patients on ART at the 
Swakopmund ART Clinic, a public health facility in an urban district of Namibia. 
 
 
 
 
24 
3.3.1 Inclusion criteria  
       HIV positive  patients who were 18 years and above,  enrolled at the Swakopmund  ART Clinic, 
who have been on ART for at least 3 months and were  stable enough  for their appointments  to 
be scheduled at least on a monthly basis. Study participants also possessed a functional cell 
phone that was able to receive SMS. 
 
3.3.2 Exclusion Criteria  
     The introduction of controls in a RCT is in order to have a control group that is similar and 
compares to the intervention group. This was achieved by refining the study population using 
exclusion criteria. The exclusion criteria were:  
• Patients who are in transit 
• All patients accessing care and treatment from the two outreach sites. 
• All patients who were already on second line ART treatment, this entails that all adult patients on 
regimens containing protease inhibitors categorized as second line regimens according to the 
national guidelines were excluded. 
• Non-ambulatory patients and those that were too ill and need to be followed up at more frequent 
intervals, or were stabilized on regimens other than the first line regimen as per the Namibian 
ART National Guidelines. 
 
3.4 Sample size 
        
      In order to detect a 60% relative reduction in the rate of missed scheduled appointments and 
based on a 14% incidence of missed appointments, with a ratio of 1:1 in both arms at a 95% 
significance level and power of 80%, 190 participants per group was calculated as the required 
sample size needed. However, in order to accommodate transfer outs and loss to follow up, the 
sample size was increased to 200 in each arm of the study to enable sufficient power to detect a 
significant difference between the two arms. Recruitment of participants into the study 
commenced on 5 December 2012 until the required sample size was reached on 30 January 2013.  
The number of patients who declined participating in the study was recorded. 
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3.5 Sampling procedure 
      
      Community counselors approached potential participants visiting the clinic or pharmacy. 
Potential subjects were invited to participate after being fully informed as to the purpose of the 
study and consent obtained from the patients. Consenting patients were assessed for eligibility 
using the inclusion and exclusion criteria. 
 
      3.5.1 Randomisation 
      Eligible subjects were randomly allocated into study groups by picking a marble from an opaque 
bag containing equal amounts of same sized and shaped red and green marbles. The colour of the 
marble was marked on both the patient’s health passport and on the recruitment register.  
 
3.5.2 Control group (standard care plus counseling) 
      All study participants received the routine standard care as prescribed by the Namibian National 
ART Guidelines (MoHSS, 2010). Patients routinely undergo 3 adherence counseling sessions 
before initiation of ART, and subsequent adherence sessions are only given to individual patients 
identified with adherence issues. Follow up review for medical and laboratory assessments were 
delivered as prescribed by the national guidelines and by physician clinical judgment. All study 
participants in the control group received adherence counseling at all follow-up visits by 
community counsellors before the outcome data was collected by the pharmacy staff. Follow up 
appointments for medication pick up were scheduled monthly or bimonthly based on other clinic 
appointments such as laboratory or clinic appointments. In order to mimic the clinic setting in 
this study as much as possible, participants were able to negotiate actual appointment intervals 
and appointment dates within a 4 – 8 weeks follow-up interval, and the actual appointment dates 
ranged between 24 – 66 days. 
 
3.5.3 Intervention group (standard care plus counseling plus SMS reminder) 
      The intervention group received an unasked for SMS reminder with a short motivational 
message which read “This is your reminder for your pharmacy appointment; we care for you and 
the date of the appointment.” The message was sent by a designated research assistant whose 
responsibility was to track medication pick up appointment dates. The reminders were sent 48 
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hours prior to their scheduled appointment but only to participants in the intervention arm of the 
study. The study numbers and date of the next appointment was recorded in the appointment 
register with the date the SMS was sent (Appendix B). The SMSes were sent in English and 
Afrikaans according to the preference of the participant. The participants in the intervention 
group also received their usual medical care in addition to counselling at every visit. Both groups 
of the study continued to receive standard care as per national guidelines. 
 
3.6 Data collection 
 
3.6.1 Socio- demographic and baseline data collection 
A pre-tested semi-structured questionnaire was used by trained counsellors to collect socio 
demographic data in a face to face interview which was held in the clinic counselling rooms. 
Structured questionnaires generally reduce the potential of collecting ambiguous answers, 
thereby strengthening the process of data collection and analysis. The interview was conducted 
in English, Afrikaans and Oshiwambo depending on the study participant’s preference. Data on 
the patient’s regimen, duration on ART and socio-demographic data such as age, employment 
status, income, marital status and the location where the patient is resident was collected. Also 
the unit of alcohol consumed daily and on weekend, the patient’s disclosure status and the 
preferred form of reminder and time the patient would like to be reminded was collected (See 
Appendix A).  
The patients’ health passport was used to validate or confirm data such as respondent’s   
regimen, date of birth, ART start date obtained from the face to face interview. 
3.6.2 Outcome of data collection 
      At every follow up visit, study participants were offered adherence counselling by community 
counsellors, thereafter they were referred to the pharmacy. The pharmacy staff on duty collected 
follow up data on appointment kept or not, pill counting, and medication adherence by 3 day 
self-reported adherence were also collected. (See Appendix B). The Aids Control Trials Group 
(ACTG) questionnaire which has been validated was adapted and incorporated into the 
participant information log sheet. Study participants were asked “how many doses did you miss 
in the last 3 days”, for the collection self-reported 3 days adherence data. 
      Adherence data for pill count was collected at the pharmacy from left over or unused medicines, 
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which were counted and recorded in the participants information log sheet. (Appendix B). In 
cases where respondents send their treatment supporters for medication refill appointments and 
hence prevented the collection of adherence data by pill count and self-report, this was noted and 
considered in the interpretation of the results.  
3.6.3 Outcome measurements 
     The primary outcome measure is the proportion of missed visits over the total number of 
scheduled appointments. 
     Secondary outcomes that were measured include the mean number of late days, which is a count 
of the number of days between the scheduled appointment date and the date study participants 
reported for medication refills. 
      ARV Adherence was measured as the proportion of doses missed in the last 3 days divided by 
the total number of doses. Oyugi et al (2004), and the proportion of participants that did not 
missed any dose in the last 3 days thereby scoring 100%. Despite variability in different 
measures of adherence, self-reported data has been shown to correlate with other measures of 
adherence such as pill counts and virological suppression, therefore a 3- day self-report is a valid 
measure of adherence.      
   . Pill counts is the percentage of the  number of doses of medicine dispensed minus  number of 
doses of medicine returned divided by the number of doses between medication refill visits. 
Unused pills were counted and recorded (Muyingo et al., 2008). We defined adherence of ≥ 95% 
as optimal adherence, while adherence of < 95% was defined as sub-optimal adherence 
(Kunutsor et al., 2010; Mbuagbaw et al, 2011). In our research setting there is no prescribed or 
schedule for tracing defaulters, therefore all study participants were attempted to be traced by 
phone call 7 days after their scheduled appointments date for medication refills. 
3.6.4 Blinding  
      Community counselors assigned to recruit and administer a pre-tested, semi-structured 
questionnaire were blinded to the allocation of participants into study groups.  This is an 
important step in reducing measurement bias as knowledge of participants grouping may 
influence how data is collected. Wood et al. (2008) stated that if allocation is not blinded to 
research staff administering allocation to groups, they are prone to influence participants into the 
intervention group, which in turn may bias the intervention effect by about 20-30%. The colour 
of marble picked determined allocation into study groups and the colour of marble which coded 
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for the intervention group and the colour which coded for the control group were concealed from 
all community counselors administering the randomization process and all pharmacy staff 
involved in collecting outcome data at every follow up visit. Blinding the pharmacy staff reduced 
the occurrence of measurement bias. Only two  research assistants designated  for  sending the 
SMSs reminder and the  chief researcher who  supervised  the  research assistants,  knew  the 
allocation of participants to the study groups  by the  colour  of the marble they picked. The chief 
researcher and research assistants responsible for sending the SMS reminder were not involved 
in data collection. 
      Study participants were not informed of the actual study intervention except that they would 
receive adherence assistance and support at every medication pick up visit. Hence, every 
participant probably thought they were in the intervention group as they were receiving the 
“intervention” of adherence assistance  
      This intervention then took the form of “adherence counseling” at every visit for the control 
group and “adherence counseling plus an SMS reminder” for the intervention group. Hence 
probably participants were blinded as to which group they were in. Adherence counseling 
covered the following themes; 
 How many doses were missed from the previous visit 
 Importance of taking medications as prescribed and consequences of interrupting 
treatment 
 Side effects experienced from the medications 
 Importance of keeping all clinic appointments 
 Unprotected sex and HIV transmission 
 
      Blinding participants should have reduced the Hawthorne effect from occurring among subjects 
in the intervention group. Unblinded subjects may become more adherent by just being aware 
they are receiving the intervention. This usually exaggerates the difference in adherence between 
the two groups.   
 
3.6.5 Contamination 
      Contamination occurs when some study participants in the control group end up getting SMS 
reminders by error. The research assistant may send SMS reminder to a subject in the control 
 
 
 
 
29 
group by error. In order to be able to prevent occurrence of contamination, the research assistant 
recorded study numbers and names to which SMS’s were sent and this register was cross 
checked against the questionnaire by the chief researcher.  Contamination might also occur by 
means of participants in the intervention arm forwarding SMS reminders to their friends who 
were given the same appointment date. Because the outcome assessors and study participants 
were blinded, we were not able to access this type of contamination by self-report. However, the 
likelihood of this kind of contamination occurring is minimal, because all the study participants 
were under the impression that the monthly adherence counselling session is the intervention. In 
addition cell phone numbers of all study participants were collected during the interview 
regardless of their group.  
3.6.6 Co-intervention  
      This occurs when some other form of intervention to increase adherence is provided to study 
participants at the same time as the study. When study participants are exposed to other forms of 
intervention   that encourages adherence to medication and to scheduled appointments, we 
cannot safely conclude that the study’s SMS intervention brought about the observed difference 
in adherence. Co-intervention can be in the form of the clinic introducing any form of reminder 
system or by a support group. However throughout the duration of this study, the ART clinic or 
any other support group known to the ART clinic did not introduce any intervention that was 
aimed at increasing adherence to appointment. It is not likely that co-intervention occurred in 
this study. 
 
3.7 Data management 
 
The questionnaires were numbered separately according to the colour of marble picked (blue or 
pink) during the randomization process. The participants study number included prefix (SN) and 
subjects serially generated number e.g. SN 234 –b2 or 235-p3 (Appendix A). The questionnaires 
were cross-checked regularly, by the chief researcher and the research assistants. Noted 
inconsistencies or data errors were corrected immediately and where this was not possible the 
error were noted and corrected at the respondents follow up visit. 
      Data cleaning was done manually  before data was entered into Microsoft Excel 2010,  also 
sample duplicate  data entry was used to assure data quality. The data validation function of 
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Microsoft Excel 2010   was   used to set validation criteria and data ranges thereby eliminating 
extraneous and ambiguous data such as three response codes in the place of two or erroneous 
data such as 120 years of age.  
 
3.8 Data analysis 
  
Data was captured on Microsoft Excel 2010 and imported into Epi Info version 7. The analysis 
of socio-demographic and base line data was summarized using descriptive measures to compare 
the results of the two groups. This gives an indication as to whether potential confounding 
factors are evenly distributed among the two groups.  
      Continuous variables such as age and duration on ART were expressed as a mean with (standard 
deviation and inter quartile range) the data on both nominal and ordinal categorical variables was 
summarized as proportions. An intention to treat principle was adopted in our analysis, this 
entails that all participants were analyzed based on the initial arm of the study they were 
randomized and grouped into, irrespective of whether they dropped out or switched group.  
3.8.1 Primary analysis: the proportion of study participants who missed appointments were 
determined, from which the cumulative incidence ratio (CIR) and risk difference (RD) were 
determined. The statistical significance was determined using the 95% confidence interval.  
3.8.2 Secondary analysis: included the determination of percentage adherence by 3-day self-
report recall and pill count. Differences in adherence between the intervention group and control 
group were determined. The prevalence rate will be used to compare the following variables- 
sex, age, location (distance from the clinic), income, treatment supporter, alcohol consumption, 
ART regimen and duration on ART between the 2 groups as a means to assess the success of 
randomization.  The mean of the number of missed days was determined for the intervention and 
control groups of the study. The association between SMS intervention and missed appointments 
was tested for statistical significance.  We also determined the association between missed 
appointments and adherence to medication by pill count and self-report. Statistical significance 
was determined at 95% CI. 
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3.9 Validity 
 
Validity is defined as the capacity of a test or question to give the true result.  In order to ensure 
rigour and validity in data collection and analysis, the following precautionary actions were 
undertaken. 
 A simple research manual outlining the purpose of the study, how to sample patients and obtain 
signed consent of eligible participants and how to ask questions and complete the questionnaires 
was produced. The research assistants who are pharmacist/pharmacy assistants and community 
counsellors were trained by the chief researcher before piloting. 
 The community counselors and pharmacy staff already have some level of competence in this 
regard moreover training will reduce cultural reinterpretation and contextual biases that may be 
associated with the use of clinic staff to interview participants. 
 The sampling   procedure adopted in this study reduced the occurrence of systematic sampling 
error. Randomisation ensures that any differences between the study sample   and the population 
are due to chance alone, it also ensures that confounding characteristics that may influence the 
outcome are evenly balanced among the two groups. Blinding of the outcome assessor at follow 
up visits reduced observer bias, for example an unblinded outcome assessor due to expectation of 
a higher adherence among the intervention arm, may exaggerate the adherence score. Blinding of 
study participants and outcome assessor until the data collection is completed also minimized the 
likelihood of systematic differences in ascertaining of outcomes between the study groups 
(Hennekens and Buring, 1987). There is currently no consensus on the standard for adherence 
measurement, pill count and self- report has been validated as acceptable instruments for 
measuring adherence in resource limited settings. (Oyugi et al., 2004; Muyingo et al., 2008). The 
likelihood of bias in measuring other outcomes in this study is also negligible for the reason that 
proportion of missed appointments and the number of missed days before honouring 
appointments are objective measures. The effect of chance is likely to be minimal as an adequate 
sample size was adopted. 
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3.10 Piloting 
      
      This study was piloted prior to commencement of the main study. In the pilot, 10 participants 
were   randomized into study groups made up of 5 participants in the intervention and control 
arm of the study. All research assistants recruited to take part in the main study participated in 
the piloting. The participants in the pilot study were not included in the main study. 
 
3.11 Reliability  
 
 Reliability refers to the consistency, repeatability and dependability of outcome measures of the 
study that is the ability of a questionnaire to produce similar results in different circumstances if 
nothing changes (Beaglehole et al., 1997).                  
      It describes how consistently observed outcomes are measured and interpreted on different 
occasions. In order to ensure data collection instrument reliability, the adherence counsellors and 
the pharmacy staff were trained and the questionnaire was tested during the piloting. All 
pharmacy staff were trained on how to fill the outcome registers. Lastly, the same trained 
adherence counselors and pharmacy staff were engaged throughout the study. 
 
3.12 Generalisability  
       
      Results from this study could be generalised to adult HIV infected patients on ART in other 
public ART clinics in urban centres in Namibia. Findings from this study would need to be 
generalised with caution to other public ART clinics in limited resource settings in other 
countries. 
 
3.13 Ethical considerations 
 
Participation in this study was voluntary for all the eligible participants on ART. Community 
counsellors explained the purpose and objectives of the study and assured prospective 
participants of confidentiality and voluntary participation without any adverse consequences 
from not participating in the study. (Participants Information Sheet Appendix C). Each 
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participant was provided with a consent form that was signed before participating in the study. 
(Informed consent Appendix D). Participants were also informed of their right to withdraw at 
any point from the study without having to provide any reasons for their withdrawal. All 
participants were given adherence counselling and support routinely available at the clinic. The 
confidentiality of participants was guaranteed because only participant’s pharmacy number was 
used as an identifier and research data were stored in a password controlled computer. The SMS 
message used was a general one so that it would not be able to deduce the participants HIV status 
based on viewing the message. This was important as the possibility of someone else viewing the 
message on participants’ phones was thought to be high. Ethical approval was granted by the 
University of the Western Cape Senate Research Committee and from the Policy Management 
Development and Research Committee of the Ministry of Health and Social Services Namibia. 
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                                               CHAPTER 4 
RESULTS 
4.1 Sample realisation  
       
      Figure 1 shows that 407 patients on ART were approached and recruited between December 
2012 and February 2013.  There was no report of any patient declining to participate in the study. 
Of the 407 patients recruited 14 (3.9%) were not eligible because they did not have a functional 
cell phone (this translates into 96.6% cell phone ownership rate)  and  5 patients were on second 
line treatment regimens (regimens containing protease inhibitors). Three hundred and eighty 
eight eligible clients were randomized into either the SMS intervention arm (n = 196) or the 
control arm (n = 192). Figure 1 shows the acquisition, follow-up and outcomes of the sample in 
the intervention and control groups. Two participants in the intervention group became lost to 
follow-up whereas 6 were lost to follow up in the control group. In addition 1 participant in the 
intervention group had his treatment stopped by the attending physician, while 4 participants, 
comprising of 1 participant from the intervention group and 3 from the control group, were 
transferred out of the facility and continued their treatment at another facility. Two participants 
dropped out from the control group without offering any reason for dropping out.  An intention 
to treat approach was adopted in the analysis, which entailed that all participants were analyzed 
based on their initially allocated group. 
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Figure 1: Flow diagram of the acquisition, randomisation and follow-up of the sample 
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4.2 Socio-economic and demographic description of participants 
 
Table 1 shows the socio-economic and demographic baseline characteristics of participants 
between the intervention and control groups.  The groups are similar for most variables which 
indicates that potentially confounding factors have been balanced in both groups through the 
randomisation process. However, the percentage of males 114 (58.2%) in the intervention group 
is fairly larger than the percentage of males 89 (46.3%) in the control group, and there is a fairly 
large difference in the single and married categories between the intervention and control groups 
as well, demonstrating that the randomisation process is not infallible. 
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Table 1: Patients socio-demographic characteristics, disclosure status, treatment supporter 
reminder and regimen characteristics at baseline in the intervention and control groups 
Variable  Intervention Group n= 196 Control Group n=192 
Age (Years) mean SD, IQR 39.8 (8.4, 34- 45) 40.5: (8.8, 34- 45.5) 
Gender     (%)    
Male 114 (58.2%) 89 (46.3%) 
Marital Status (%)  
   
Single 88 (44.9%)      104 (54.1%)   
Married 61 (31.1%)       44 (22.9%)      
Widowed 7 (3.6%)             4 (2%) 
Divorced/Separated 4 (2%)               4 (2%)              
Co-habiting 33 (16.8%)        36 (18.8%)  
Location (%)   
Tamariskia  4km from facility 5 (2.6%) 4 (2.1%)            
Mondesa     5km from facility 64 (32.7%) 70 (36.5%) 
Tulinawa      8km from facility 31 (15.8%)         33 (17.2%) 
DRC               15km from facility 76 (38.8%)       74 (38.5%) 
Vineta            5km from facility 2 (1%) 2 (1%) 
Town             3km from facility 3 (1.5%) 1 (0.5%) 
Nonidas        15km from facility 2 (1%)    2 (1%) 
Others 6 (3%) 1 (0.5%) 
Employment (%)  n=193 n=191 
Employed 139 (70.9%)       133 (69.3%)       
Type of Employment (%)     
Government 2 (1.4%)              2(1.5%)              
Private company 103 (72.5%)        99(74.4%)       
farm 10(7%)                  10 (7.5%)          
Self employed 27(19%)               22 (16.5%)        
Monthly Income N$ mean (SD,IQR) 2,110 (1,772, 1000 – 2700) 2,161 (1,774, 900 – 3000) 
Alcohol consumption (%)         
Yes 56 (28.9%)          55 (28.8%)      
Units alcohol  consumed mean (SD,IQR)   
Units/ weekend 2.3 (1.3, 1 – 3) 2.4 (1.5, 1- 3)  
Units /per day 2 (0.4, 0 – 2) 1.3 (1.17,0.2 – 2) 
Treatment characteristics   
First line treatment regimens (%)           
AZT/3TC/NVP 74 (37.9%)  63 (32.8%) 
AZT/3TC/EFV 17 (8.7%)   20 (10.4%) 
TDF/3TC/NVP 67 (33.9%)        86(44.8%)   
TDF/3TC/EFV 34(17.4%) 22(11.5%) 
D4T/3TC/NVP 3(1.5%)  1(0.5%) 
D4T/3TC/EFV  1(0.5%) 0 
Duration on ART (Years) mean SD IQR 3.54 (2.40; 2.00-5.00) 3.68 (2.39; 2.00-5.00) 
Treatment supporter      (%)         
  
Yes 179   (92.3%) 174 (90.6%) 
Treatment Supporter reminder     (%)         n=179 n=174 
Always 107 (59.4%)  94 (51.9%) 
Occasionally  40 (22.2%) 44 (24.3%) 
Never 33(18.3%)  43 (23.7%) 
 Status Disclosure    (%)        Yes 175 (93.6%) 171 (90.9%) 
Type of regimens     (%)      
                                                   once daily 34 (17.3%) 22(11.5%) 
 
 
 
 
 
38 
4.3 Participants preferences regarding SMS telephonic reminders 
 
Table 2 shows the proportion of study participants who wanted a telephonic appointment 
reminder. Among those that preferred to receive a telephonic appointment reminder, their 
preferred type of reminder (SMS, or call, or both), their preferred time for receipt of the reminder 
and whether they have shared a phone with someone or not, is described as well. Out of the 388 
participants randomized into the study, 137 (35%) preferred not to be reminded of their 
scheduled medication pick-up appointment. In principle unsolicited SMS reminders were sent to 
participants who preferred not to be reminded of their medication appointment. Of the 251 study 
participants that preferred to be reminded of their appointments, 130 (52%) preferred to be 
reminded with SMS only and 136 (54%) did not object to being reminded at any time of the day. 
Telephonic appointment reminders may be perceived as being intrusive on patients’ privacy and 
could result in a break in confidentiality especially if patients share their phone with others. 
However, in this study only 81(21.6%) of study participants shared their phone with others. 
Table 2: Proportion of patients who prefer to be reminded of their medication 
appointments, type of reminder, preferred timing of the reminder and shared phone usage 
Variable Intervention Control 
Would like a Reminder or not n=196 n=192 
Wanted a reminder 131 (66.8%) 120 (62.5%) 
Type of Reminder Preference  n=131 n=120 
Calls only 26 (19.6) 15 (12.4) 
SMS only 62 (47.3) 68 (56.2) 
Calls & SMS 43 (32.8) 37 (31.4) 
How many days before your appointment 
do you prefer to receive your reminder  
 
n=129 
 
n = 120 
1 38 (29.5) 31 (25.8) 
2 50(38.8) 48 (40) 
3 33(25.9) 19 (15.8) 
4 3 (2.3) 12(10) 
5 5(3.9) 10 (8.3) 
Preferred time of the day n = 129 n = 120 
Morning 32 (24.8) 32 (26.7) 
Afternoon 20 (15.5) 15 (12.5) 
Evening 5 (3.9) 9(7.5) 
Anytime 72 (55.8) 64 (53.3) 
Phone sharing  n = 185 n = 189 
Yes 39 (21.1) 42 (22.2) 
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4.4 The absolute and relative association between SMS reminders and socio demographic 
parameters on adherence to medication pick up appointments 
 
Participants who were on-time for all the four scheduled medication refill appointments were 
considered to have kept their appointment, whereas participants who were late for any of the 
scheduled medication refill appointments were considered to have missed the appointment. 
In this study a ‘strict definition’ of on-time for a scheduled medication appointment required that 
participants show up for their medication refill on the scheduled appointment date. In the case of 
the ‘loose definition’ criteria, participants who showed up for medication refill appointment one 
to two days after the scheduled appointment date were considered to be on-time.  
Table 3 demonstrates the association between the SMS reminder intervention (and other 
independent variables) and the outcome variable of whether the medication appointment was 
kept or not. The relative risk was measured as the cumulative incidence ratio (CIR) while the 
absolute effect was measured as the risk difference (RD). The CIR as well as the RD showed a 
statistically significant association between the SMS intervention and adherence to scheduled 
ARV pick up appointments. None of the socio-demographic characteristics of the patients 
evaluated in this study showed statistically significant associations with adherence to medication 
pick up appointments. 
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Table 3: Bivariate analysis of the absolute and relative association between SMS reminders 
and socio-demographic variables on adherence to medication pick up appointments. 
Variable 
Kept all medication 
appointments 
Missed medication 
Appointment  
CIR (95% CI) 
Risk Difference (95% CI) 
Received SMS reminder 112 (57.1%) 84(42.9%) 1.61 (1.29 – 2.02) 21.7 (12 – 31.4) 
Control 
68 (35.4%) 124 (64.6%)    
Gender        
Female  89 (48.1%) 96(51.9%) 1.07 (0.87-1.33) 3.3 (-6.7 – 13.2) 
Male 91(44.8%) 112(55.2%)    
Alcohol consumption        
≤ 1 units/day & ≤ 2 units/weekend  158(47%) 178(53%) 1.09 (0.78-1.52) 3.9 (-10.7 – 18.5) 
> 1 units/day & or > 2 units/weekend 22(43.1%) 29(56.9%)    
Age        
40 - 70 years 95(48.2%) 102(51.8%) 1.08 (0.87 - 1.34) 3.7 (-6.2  – 13.6) 
18 -39 years 85(44.5%) 106(55.5%)    
Disclosure status       
 
Disclosed 160(46.2%) 186(53.8%) 1.02 (0.68 - 1.53) 1.1 (- 17.2 – 19.4) 
Non-Disclosure 
14(45.2%) 17(54.8%)    
Duration on ART         
 
 ≤ 1 year 25(35.7%) 45(64.3%) 0.73 (0.52 - 1.02) -13.0 (- 25.5 –( - 0.53) 
> 1 year  
155(48.7%) 163(51.3%)    
Employment        
Employed  133(48.7%) 140(51.3%) 1.21 (0.94 - 1.57) 8.5 ( -2.3 – 19.4) 
Unemployed 45(40.2%) 67(59.8%)    
Location from facility       
 
Live near  facility  67(44.4%) 84(55.6%) 0.94 (0.75- 1.18) - 2.9 ( -13.0 – 7.3) 
Live far from facility 
111(47.2%) 124(52.8%)    
Monthly Income          
> N$1000 90(49.2%) 93(50.8%) 1.12 (0.90 - 1.39) 5.28 ( - 4.7 – 15.2) 
≤ N$ 1000 90(43.9%) 115(56.1%)    
Marital status        
Single/widowed/separated/divorced 96(45.7%) 114(54.3%) 0.97 (0.78 - 1.20) -1.4 ( -11.4 – 8.6) 
married/cohabiting 82(47.1%) 92(52.9%)    
Preference to be  reminded     
Needs reminder  120(47.8%) 131(52.2%) 1.11(0.88-1.42) 4.9 (-5.54 – 15.2) 
Does not want to be reminded  58(43%) 77(57%)   
Treatment Supporter reminder        
 
Always/occasionally 130 (45.8%) 154 (54.2%) 0.91 (0.71–1.2) - 4.2 ( -8.4 – 16.9) 
Never 
38(50.0%) 38 (50%)    
 
    
Regimens 
    
Once daily regimens 32(57.1%) 24(42.9%) 1.28(0.99 – 1.66) 12.6 (-1.46 – 26.6) 
Twice daily regimens 
148(44.6%) 184(55.4%)   
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4.5 The absolute and relative association between SMS reminders and other independent 
factors and adherence to antiretroviral medications. 
 
Table 4 shows the association between SMS intervention and adherence to medications as well 
as the association between keeping ARV pick up appointments and adherence to medications. 
Evidence from studies on adherence amongst patients with chronic disease conditions suggests 
that self-reported measures of adherence are often biased upward. Hence for the self-reported 
measure of adherence to medication, we adopted beforehand a 100% cut–off point which 
represents an upper bound estimate (Gilford et al., 2000). Expectedly, a significantly higher self-
reported adherence was recorded as compared to pill count adherence.  Participants who received 
the SMS reminder were slightly more likely to be adherent to their medication, while participants 
who kept all medication pick up appointments were two times more likely to attain optimal 
adherence to their medication. Table 4 also shows the association between some socio-
demographic characteristics of patients and achieving optimal adherence. Our findings shows 
that only those employed were more likely to attain optimal adherence. On the other hand, adults 
who are less than 39 years old are less likely to achieve optimal medication adherence as 
compared to adults who are above 40 years of age. 
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Table 4: Bivariate analysis of the absolute and relative association between SMS reminders, keeping appointments and 
patients socio-demographic characteristics and adherence to medications. 
          Adherence  by pill count   Adherence by self-report 
 
Optimal 
adherence        
≥95%  
Sub 
optimal 
Adherence                 
< 95% 
CIR 95% CI RD (95% CI) 
 
Optimal 
adherence        
100%  
Sub 
optimal 
Adherence                 
< 100% 
CIR 95% CI 
 
RD (95% CI) 
Intervention                                      SMS  intervention 149 47 
 
1.14 (1.01-1.30) 
 
11.4 (2.4 -20.5) 
 
171 25 
1.18 (1.07 –1.31) 
  
14.3 (6.5 – 22.2) 
                                                            Control 127 65 
 
140 52 
Kept appointments                  Kept all  appointment 171 6 1.9(1.69- 2.24) 
 
46.9(39.6 -54.4) 
 
172 5 
1.47 (1.33- 1.62) 
  
29.8(22.8-36.8) 
                                                      Missed appointment 
104 106 
 
139 71 
Alcohol:           ≤ 1 units/day & or  ≤ 2 units/weekend  233 103 
 
0.90 (0.77 1.07) 
 -7.1(-19.8-5.5) 
 
266 70 0.92 (0.81 - 1.03) 
  -7.1(-17.5-3.3) 
                           > 1 units/day & or > 2 units/weekend 39 12 
 
44 7 
Age:                                                                40-70 years 127 64 
 
0.87( 0.77-0.99) 
 -9.7(-18.7--0.63) 
 
149 42 0.94 (0.85 - 1.04) 
  -4.2(-12.2-3.7) 
                                                                       18-39 years 149 48 
 
162 35 
Employment:                                               Employed 207 66 
1.26 (1.07 – 1.49) 
 14.9(4.5-25.3) 
 
231 42 
1.19 (1.05 –1.36) 
  
 
13.7(4.2-23.2) 
                                                                     Unemployed 67 45 
 
79 33 
Gender:                                                                  Female 128 57 
 
1.05 (0.93 – 1.20) 
 -4.3(-13.4-4.8) 
 147 38 0.98 (0.89 - 1.08) 
  
 
-1.3(-9.3-6.6) 
                                                                                    Male 148 55 
 
165 38 
Marital status: Single/widowed/separated/divorced 149 61 
 
1.04(0.92- 1.19) 
 1.4(-7.8-10.6) 
 
171 39 1.05(0.95 – 1.16) 
  3.3(-4.8-11.3) 
                                                           married/cohabiting 121 53 
 
136 38 
Location:                                               Live near Facility 105 45 
 
0.97(0.85 – 1.11) 
 -2.2(-11.6-7.2) 
 
116 34 0.94(0.84 -1.04) 
  
 
-4.2(-12.5-4.1) 
                                                           Live far from facility 169 66 
 
193 42 
Monthly Income:                                            > N$ 1000  134 49 
 
1.07 (0.95-1.23) 
 -5.4(-3.6-14.5) 
 
153 30 1.08(0.98 – 1.19) 
  -6.5(-14.4-1.3) 
                                                                            ≤ N$ 1000 139 66 
 
158 47 
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4.6 The absolute and relative association between various independent variables and 
adherence to antiretroviral medications 
 
Table 5 highlights the absolute and relative association between patients preference to be 
reminded or not, HIV disclosure status, receiving a reminder by a treatment supporter, type of 
treatment regimen and adherence to medication. The results from the bivariate model 
demonstrate no statistical significance between any of the variables and achieving optimal 
adherence as assessed by both pill count and self-report.  
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Table 5: Bivariate analysis of the absolute and relative association between patients preference to be reminded or not, 
disclosure status, reminder by treatment supporter, type of regimen and telephonic SMS reminder on medication adherence. 
 
         Adherence  by pill count 
Adherence by self-report 
 Optimal 
adherence        
≥95% 
Sub 
optimal 
Adherence                 
< 95% 
CIR 95% CI RD (95% CI Optimal 
adherence        
100% 
Sub 
optimal 
Adherence                 
< 100% 
CIR 95% CI RD (95% CI) 
Reminded by treatment Supporter:  
 
                                                             Always/occasionally 196 88 
 
0.95(0.89-1.12)) 
 
-3.4(-14.8-8.0) 
 
226 
 
58 
0.94 (0.84 –1.04) 
  
-6.0(-15.1-3.3) 
 
 
                                                                                    Never 55 21 
65 11 
ART Regimens:                                 Once daily regimens 43 13 
 
 
1.02 (0.90 - 1.17) 
 7.5(-4.6-19.6) 
46 10  
1.10( 0.94- 1.30) 
  
 
2.3(-8.6-13.2) 
                                                           Twice daily  regimens              
 233 99 266 66 
Disclosure status:                                           Disclosed 243 103 
 
0.87 (0.72 - 1.04) 
 -7.5(-22.9-8.0) 
275 71 
0.91 (0.79 –1.05) 
  
-7.9(-20.5 – 4.7) 
                                                                     Non disclosed 25 6 27 4 
Duration on ART:                                                ≤ 1 year 41 26 
 
0.83(0.68 – 1.01) 
 -12.6(-25.1--0.2) 
54 13 
0.99(0.87 – 1.13) 
  
-0.2(10.5-10.2) 
                                                                               > 1 year 233 84 255 62 
   
  
   
 
Preference to be reminded: 
Need reminder 
 98 37 
 
1.01 (0.89 - 1.16) 
 1.4(-8.1-10.9) 
113 22 
1.07 (0.87 –1.18)  
  
5.6(-2.5-13.7) 
                                        Does not want to be reminded 176 75 197 54 
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4.7 Independent predictors of adherence to appointments for medication pick-up 
 
In this study, although we found that only the SMS intervention was significantly associated with 
adherence to scheduled medication pick up appointments, we treated all variables with a p value 
≤ 0.1 as potential confounders and proceeded to assess their effect via backward stepwise 
regression multivariate logistic model, which initially included all variables with the above 
criterion. Table 6 shows the initial multivariate logistic model.  
Table 6: Multivariate logistic regression analyses of potential predictors of honouring 
medication pick up appointments with all variables with a P value of 0.1 or lower on 
bivariate analysis included. 
Variable 
 
Adjusted CIR 95%CI 
p-value 
Group: 
SMS Intervention 
 
 3.51(2.03-6.05) 0.00 
control 
Duration on ART: 
≤ 1year 
 
 0.84(0.41-1.74)  0.64 
>1year 
Treatment supporter reminder: 
Always/occasionally  0.79(0.40-1.57)  0.51 
Never 
Employment status: 
employed 
 
 1.61(0.86-2.99)  0.14 
unemployed 
Regimens Type 
Once daily regimens 1.70 (0.77-3.76) 0.19 
Twice daily regimens 
Reminder preference 
willing to be reminded 0.79 (0.52-1.18) 0.24 
Not willing to be reminded 
 
Table 7 shows the final multivariable logistic regression model using a backward stepwise 
approach, after all variables which after initial inclusion had a P value of greater than 0.2 were 
removed from the subsequent models.  The final model showed an independent association of 
SMS intervention with adherence to appointments.  
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Table 7: Final backward stepwise regression model of predictors of honouring medication 
appointment pick ups. 
Variable 
 
Adjusted CIR 95%CI 
p-value 
Group: 
SMS Intervention 
 2.65(1.72-4.08) 0.00 
control 
Regimens Type 
Once daily regimens 
1.52 (0.84-2.73) 0.16 
Twice daily regimens 
 
 
4.8 Independent predictors of adherence to antiretroviral medications 
 
Table 8 shows the predictors of adherence to medications assessed by pill count in a multivariate 
logistic regression analysis. As before, we used a backward stepwise regression multivariate 
logistic model, which initially included all variables with a p value ≤ 0.1 as potential 
confounders.  
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Table 8: Multivariate logistic regression analysis to determine predictors of medication 
adherence as assessed by pill count and self-report, with all variables with a P value of 0.1 
or lower on bivariate analysis included. 
 Pill count 3 days self-report 
Variable Adjusted  CIR 
95%CI 
P value Adjusted  CIR 
95%CI 
P value 
Group: 
SMS intervention  
 1.25(0.71-2.20) 
 
 0.43 
 2.31(1.23-4.36)  0.00 
control 
Adherence to appointments: 
Kept all medication appointments  
 20.99(9.59-45.97) 
 
0.00 
 
 9.43(4.11-21.67) 
 
 
0.00  
Missed medication appointment 
Alcohol:   
≤ 1 units/day and  ≤ 2 
units/weekend  
 
 1.84(0.82-4.16) 
 
 0.14 
1.85(0.70-4.91) 
 
 0.21 
> 1 units/day and> 2 
units/weekend 
Employment status: 
employed 
 
 1.91(1.06-3.42) 
 
  0.03 
 1.97(1.07-3.63)  0 .02 
unemployed 
Disclosure Status: 
Disclosed status 
 
 
 0.76(0.27-2.12) 
 
 
 0.60 
 0.64(0.19-2.10)  0.46 
Non –Disclosed status 
Treatment-Supporter 
Reminder: 
Always/occasionally 
 
 1.18(0.59-2.35) 
 
 0.65 
0.77(0.36-1.67)  0.51 
Never 
Age: 
40 – 70 years  
 0.69(0.40-1.20) 
 
 0.19 
 1.01(0.57-1.88)  0.91 
18 – 39 years 
 
Table 9 shows the final model using a backward stepwise approach to determine the predictors 
of adherence to medications with variables having a P value > 0.2 being removed at each stage. 
Table 9 shows that receiving a telephonic SMS reminder and employment status are independent 
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predictors of adherence to antiretroviral medication 
 
Table 9: Final backward stepwise regression model of predictors of adherence to 
medication as assessed via pill count and 3 day self-report. 
 Pill Count 3 Days Self-report 
Variable Adjusted  CIR 
95%CI 
P value 
Adjusted  CIR 
95%CI 
P 
value 
Group 
SMS intervention 1.15(0.68-1.95)  0.59  2.07(1.16-3.71)  0.01 
control 
Adherence to appointments: 
Kept all medication appointments  
 21.61(10.00-46.68) 
 
0.00 
 
 10.63(4.69-24.13) 
 
 
0.00  
Missed medication appointment 
Employment status: 
employed 
 
  1.97(1.13-3.42) 
 
0.02 
 2.16(1.22-3.82) 0.00 
unemployed 
 
In the final multivariate model, after removing kept medication appointments as it is likely to be 
an intermediate variable between receiving an SMS reminder and adherence to medication we 
found receiving an SMS reminder and being employed to be independently positively associated 
with adherence to antiretroviral medication (on both pill counts and self-report).  
 
Table 10: Backward stepwise regression model of predictors of adherence to ART via pill 
count adherence measurement and 3day self-report of adherence, with ‘adherence to 
appointments excluded. 
 Pill Count 3 Days Self-report 
Variable 
Adjusted  CIR 
95%CI 
P value 
Adjusted  CIR 
95%CI 
P value 
Group 
SMS intervention 1.84  (1.17 – 2.88) 0.00 2.81 (1.63 – 4.04) 0.00 
control 
Employment status 
employed  
1.95 (1.21 – 3.11) 
 
0.00 
 
2.18 (1.28 –3.72) 
 
 
0.00 
unemployed 
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4.9 The influence of patients’ preference to be reminded or not as a potential effect 
modifier on adherence to medication appointments for strict and loose criteria. 
 
Table 11 shows the sub analysis of adherence to medication appointments stratified by 
participants preference to receive a telephonic/SMS reminders or not. The absolute and relative 
effect of SMS reminders on adherence to medication appointments for both strict and loose 
adherence to medication appointment is also highlighted. We noted that those who ‘preferred to 
receive a telephonic/SMS reminder’ had a greater risk difference and cumulative incidence ratio 
than those who ‘preferred not to receive a telephonic/SMS reminder’ for both strict and loose 
adherence criteria adherence to appointments, which was statistically significant for the loose 
criteria but not for the strict criteria. This suggests that ‘preferred to receive a telephonic/SMS 
reminder’ is probably an effect modifier for adherence to appointments. 
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Table 11: Participants preference to receive reminders and its influence as a potential effect modifier on adherence to 
medication appointments for strict and loose criteria 
 
 
 
 
 
 
 
 
 
   Strict criteria  Loose criteria 
  Kept all 
appointment 
Missed 
appointment 
CIR 95% CI RD 95%CI Kept all 
appointment 
Missed 
appointment 
CIR 95% CI RD 95%CI 
All participants: 
regardless of 
preference 
                                              
SMS  intervention n=196 
112 84 
1.61(1.29-2.02) 21.7(12.0-31.4) 
144 52 
1.47(1.25-1.73) 23.5(14.1-32.9) 
                                                                       
Control                    n=192 
68 124 96 96 
Preferred to be 
reminded 
                                              
SMS  intervention n=131 
80 51 
1.83(1.37-2.44) 27.7(13.9-39.6) 
99 32 
1.71(1.59-2.14) 31.4(19.9-42.9) 
                                                                       
Control                    n=120 
40 80 53 67 
Preferred not to be 
reminded 
                                               
SMS  intervention  n=63 
30 33 
1.61(0.83-1.80) 8.7(-7.9-25.4) 
43 20 
1.14(0.89-1.47) 8.5(-7.6-24.7) 
           control           n=72                                                 
Control 
28 44 43 29 
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4.10 The influence of patients’ preference to be reminded or not as a potential effect 
modifier on adherence to medication.  
 
Table 12 shows the results from the sub-analysis of the influence of the SMS intervention on 
medication adherence among patients who indicated a preference on whether “to be reminded or 
not to be reminded” of their medication refill appointments during the pre-intervention survey. 
The results indicate that SMS reminders had a statistically significant positive association with 
adherence to medication among the cohort of patients who were willing to be reminded of their 
appointments, but not amongst those who were not willing to be reminded of their appointments. 
The actual CIR and RD differences between the two groups (prefer SMS reminder and prefer not 
to receive SMS reminder) were however small and were not statistically significant. This 
however still suggests that, although not conclusively shown by this study, willingness to receive 
a SMS reminder probably acts as an effect modifier on the relationship between receiving a SMS 
reminder and adherence to medication. 
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Table 12: Participants preference to receive reminders and its influence as a potential effect modifier on medication adherence 
assessed pill count and 3 day self –report. 
   Adherence by pill count  Adherence by self-report 
 Intervention Optimal 
adherence        
≥95%  
Sub 
optimal 
Adherenc
e                 
< 95% 
CIR 95% CI RD 95%CI Optimal 
adherence        
100%  
Sub 
optimal 
Adherenc
e                 
< 100% 
CIR 95% CI RD 95%CI 
All participants: 
regardless of 
preference 
                                            
SMS  intervention 
149 47 
1.14(1.01-1.31) 11.4(2.4-20.5) 
171 25 
1.18(1.07-1.31) 14.3(6.5-22.2) 
                                                                        
Control 
127 65 140 52 
Preferred to be 
reminded 
                                              
SMS  intervention 
102 29 
1.28(1.08-1.52) 17.0(5.8-28.3) 
113 18 
1.25(1.08-1.43) 17.1(6.9-27.2) 
                                                                        
Control 
73 47 83 37 
Preferred not to 
be reminded 
                                             
SMS  intervention 
45 18 
1.00(0.21-1.25) 0.6(-14.7-15.9) 
56 7 
1.12(0.96-1.30) 9.72(-2.5-21.9) 
                                                                        
Control 
51 21 57 15 
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4.11 Number of late Days 
 
A Risk Difference (Attributable risk) of 22% 95% CI (12.1 – 31.5) was recorded for SMS 
reminders and missed appointments in this study. The mean number of days late was 3.8 and 8.3 
days for the SMS and control groups respectively with a statistically significant mean difference 
of 4.4 days late 95% CI (2.7 – 6.2).  
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                                                   Chapter 5 
                                                   Discussion 
5.1 Introduction 
       
      This chapter discusses the findings from the study on the effectiveness of motivational 
telephonic SMS reminders influence on adherence to medication pick up appointments as well as 
adherence to antiretroviral medications at the Swakopmund State Hospital ART clinic. The 
influence of participants socio-economic and demographic characteristics on the effectiveness of 
SMS reminders to adherence is also discussed in this chapter. In addition the association between 
adherence to scheduled medication refill appointments and adherence to medications was 
explored. 
 
5.2 SMS reminders and adherence to scheduled medication pick up appointments 
 
Scheduled medication pick up appointments significantly increased the likelihood of honoring all 
medication appointments in an urban HIV setting in Namibia. The results shows that study 
participants that received the SMS reminder were 1.6 times more likely to honour all medication 
pick up appointments as compared to participants that did not receive the SMS reminder. 
Additionally, after adjusting for duration on ART, treatment supporter reminder, employment 
status and the patient preference of receiving reminder or not, the final multivariate model 
demonstrates that SMS reminder is an independent  predictor of adherence to  scheduled 
medication pick up appointments with CIR 2.65 (95% CI: 1.72-4.08).The risk difference 
indicates that the SMS intervention reduced the risk of missing medication pick up appointment 
by about 22% as compared to participants that did not receive the reminder. 
In this study, a strict and a loose criterion were set beforehand for on-time medication pick up 
appointments. This is due to the fact that in routine clinic practice, patients are normally given 
extra medicines to cover for 2 days after the scheduled appointment date (MoHSS, 2014). 
Expectedly, more participants kept all appointments using the loose criteria as compared to the 
strict criteria, and it is important to note that our result shows that the SMS intervention 
improved the likelihood of honoring all appointments in both the strict and loose criteria for on-
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time pick up for medication. Despite the positive results we found for the effect of the SMS 
intervention on adherence to medication appointments, we should be circumspect about this 
finding as evidence for the effectiveness of SMS reminders on attendance rate is sparse and has 
not been consistent. A study from a rural clinic in Sierra Leone showed that daily SMS 
reminders sent 2 days prior to clinic appointments did not improve adherence to medication 
appointments (Kelly et al., 2012).  Even though that study was an RCT, it was limited by an 
inadequate sample size and short evaluation period. Likewise, a randomized control study 
conducted in Switzerland in which phone call, SMS reminder and postal reminders were sent 
sequentially to patients in a primary health clinic,  reduced missed appointment from  11.4% to 
7.8%, however sub analysis of the effect of the sequential intervention in the HIV outpatient 
department did not show significant improvement in attendance rate (Perron et al., 2010), on the 
contrary, the positive results from this current study are corroborated by the findings from 2 
systematic reviews. In the systematic review made up of 8 RCTs and 10 observational studies 
reported by Rebecca et al. (2012) it was found that the SMS reminder increased the likelihood of 
kept appointment by 50% as compared to participants that did not receive the reminder in 
primary health care and hospital outpatient settings. In this review, SMS reminders were 
significantly associated with the likelihood of honouring clinic appointments with a RR of 1.48 
(95% CI: 1.23-1.72) with no significant sub group differences by clinic type. 
      Likewise, in another systematic review of 8 RCTs involving 6,615 participants, Gurol-Urganci et 
al. (2013), reported that 7 out of the 8 RCTs showed  that SMS reminders substantially improved 
attendance rates of clinic appointments as compared to no reminders with a RR 1.14( 95% CI: 
1.03-1.26) in primary health care  and hospital outpatient settings. It is important to note that the 
types of clinics in the hospital outpatient settings were not specified in both systematic reviews. 
It is also worth noting that in our current study the participants in the control arm had a higher 
adherence to medication pick-up appointments than that found in the 2012 Namibian National 
Adherence Baseline Survey (Tjijuka et al. 2013). Whether this is due to inherent higher than 
national average adherence at Swakopmund State Hospital, or whether the counselling at each 
visit resulted in an increased adherence among the patients at Swakopmund State Hospital is 
unclear, and since counselling at every appointment has become standard care, we could not 
ethically include an additional ‘without counseling arm’ to this study.  
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Preference to receive SMS/telephonic reminders or not and adherence to medication 
appointment: The use of mobile phones has been shown to improve service utilization among 
population groups such as teenagers and young adults, however it has been noted that a 
significant proportion of older adults may be less able or willing to use mobile phones hence 
limiting the potential benefit in this population group (Horvart et al., 2012). The pre-survey 
revealed that 35% of study participants preferred not to be reminded of their medication pick up 
appointments. It is not unlikely that the concern of stigma and discrimination associated with 
HIV infection may be one of the factors responsible for unwillingness to receive reminders by 
some patients. Stigma and discrimination associated with HIV infection may either be perceived 
or real, for instance over 10% of respondents in the National adherence baseline survey of 2012 
reported that employers refused to give permission to take time off for clinic visits and likewise, 
10%  of patients did not want it to be known that they were receiving ARVs. Sub analysis of 
participants preference to be reminded or not to be reminded showed a higher CIR and RD 
among patients who preferred to receive an SMS reminder, for honouring all medication 
appointments using the strict criteria. It is important that policy makers consider participants 
need or willingness to receive reminders in the rollout of the SMS intervention, even though an 
improvement was noted even among patients that did not want a reminder as we anticipate a 
more cost effective intervention among patients willing to receive the SMS reminder, due to the 
higher likelihood of it being more effective in this group.  
     The timing of the reminder: Data from this study suggests that patients preferences for timing of 
the telephonic SMS reminder varied and it was evenly spread out over 1-3 days, which makes it 
quite difficult to choose the best time to send the SMS reminder. It is also likely that if the 
reminder were to be sent daily repetitively over the commonest time period chosen, of 3 days, 
then the problem of patients getting annoyed by the repeated SMSes which might appear as  
“spam”, may not be ruled out. In this same vein, Pop-Elleches et al. (2012) reported that more 
frequent and repeated reminders may bring about a diminishing effect in adherence and in 
particular he reported that daily SMS reminders were less effective compared to weekly SMS 
reminders, on adherence to ART. Taking this insight into consideration and noting that over 67% 
of study participants who indicated a need for a reminder in the pre-intervention survey, 
preferred to receive their reminder 2 days prior to their scheduled medication pick up 
appointment, we opted to deliver the intervention 2 days prior to scheduled medication pick up 
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appointments. Furthermore, results from a meta-analysis of 7 RCTs reported by Guy et al.,(2012) 
showed no significant sub group differences by message timing of reminders delivered 24, 48 
and 72 hours prior to scheduled appointments.    
Message content and adherence to medication appointments: Telephonic / SMS preventive 
health programs are theoretically more likely to demonstrate greater impact potential if their 
content is based on evidence of effectiveness and follows the advice of behavioral change theory 
(Fry and Neff, 2009).We acknowledge that this intervention was not based on any specific 
behavioral change theory such as the health belief model or the theory of planned behavior. 
However, it has been proven that SMS reminders are an effective means of support, 
encouragement and reinforcement of positive health behaviors even when the intervention is not 
specifically based on any change theory (Cole-Lewis and Kershaw, 2010). It is important to note 
that this intervention was based on the evidence that forgetfulness is a major reason reported by 
patients at Swakopmund for missing or not keeping scheduled clinic or medication pick up 
appointments. The Namibia national adherence baseline survey of 2012 also revealed that 67% 
of patients reported forgetfulness as the major reason for not keeping scheduled medication refill 
appointments (Tjijuka et al., 2010).The impact of the message content on the outcome of the 
intervention cannot be fully ascertained because there is sparse evidence to suggest that the way 
the message is framed may influence patients response to making a behavioral change or not, 
however Pop-Elleches (2010) showed that the length of the message does not influence 
adherence. Despite the rejoinder by Pop-Elleches above, we thought it prudent to steer clear of 
long and potentially annoying messages, therefore in this study the message was kept short and 
simple: “This is your reminder; we care for you and the appointment date”. However, for an HIV 
setting, it is important that the message be discreet because of privacy and confidentiality 
concerns. Considering the fact that about 22% of the study participants reported shared phone 
usage, it was therefore imperative that the SMS message be communicated in such a way that 
patients HIV status was not inadvertently disclosed to third parties.  
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5.3 Association between adherence to scheduled medication pick up appointments and 
achieving optimal antiretroviral medication adherence. 
 
This study demonstrates  that patients who kept all scheduled  medication pick up appointments 
are two times more likely to achieve optimal adherenceto ART,as compared to those who miss 
one or morescheduled medication appointments, with a large and significant  risk difference for 
both adherence assessed by pill count 47% and self-reported adherence 30%. Similarly, results 
from the bivariate analysis  indicates a statistically significant positive association (both relative 
and absolute) between adherence to appointments and acheiving optimal adherence to 
medication. However, the adjusted CIR increased significantly from the bivariate level, 
demonstrating that keeping all medication appointments is a partial or intermediate predictor of 
adherence to ART, because patients who received the SMS reminder are more likely to keep all 
appointments and those who achieve optimal adherence to ART are also more likely to honour 
all medication appointments. This correlation between keeping medication appointments and 
adherence to ART has been described by Kunutsor and colleagues, (2010) in a rural hospital in 
Uganda, in which a cohort of treatment experienced patients on ART were followed up for 28 
weeks. Interestingly, adherence was assessed by both clinic based pill counts and self-reported 
adherence, with similar definitions of optimal adherence as adopted in the current study. Their 
result showed that adherence to appointments is a strong predictor of adherence medications. 
Even though we could not correlate adherence to viral suppression or clinical outcome due to 
cost and logistic constraints, Park et al., (2007) in a prospective cohort study in which 387 
patients were followed up for one year after initiating ART in an urban referral hospital in South 
Korea, found missed clinic visits to be a strong predictor of poor clinical outcome in HIV 
infected patients. Moreover, previous studies done in resource limited settings have also 
correlated pill count and self-reported adherence measures to patients viral load suppression. We 
therefore do not envisage that the detractive value of this study will be much affected by the non-
assessment of patients’ viral load and other clinical outcomes, as there is evidence for this link 
(Elul et al., 2011; Mugavero et al., 2010). 
Regardless of documented challenges associated with pill count such as patients dumping pills, 
as well as patients not coming to the pharmacy with left-over pills and the social desirability and 
recall biases associated with self-reported measure of adherence, and while  acknowledging that 
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both methods tend to overestimate adherence, pill count and self-report still remains the only 
practicable tools for the monitoring and the assessement of adherence to ART in resource-
constrained settings (WHO, 2006). Despite its fallibility pill count and self-report are quite 
difficult to measure and require a considerable  investment of resources and staff time if used as 
a monitoring tool of medication adherence. In the light of the above, and noting that monitoring 
patients adherence to medication is critical to maintaining the continuum of health care for 
PLHIV, using adherence to medication pick up appointments would be a useful and easy to 
monitor proxy measure and has the added benefit of being able to monitor the retention of 
patients in care (Tjijuka et al., 2012). As noted from our results discussed above, patients 
appointment keeping behaviour could indeed be used as a proxy marker for identifying non 
adherent patients to ART and would be especially useful in a resource-constrained setting. 
Considering the fact that at the Swakopmund State Hospital  ART clinic patients visit the clinic 
more frequently for medication pick ups as compared to medical visits, and as such  adherence 
issues are more likely to be identified  and detected earlier during medication pick up visits from  
missed appointments. Furthermore, the appointment keeping data of patients could be tracked 
manually on the patients health passport and also electronically. In addition the use of the 
medication pick up appointment data is cost effective and easily retrivable by pharmacy staff 
and can be shared with the rest of the medical team for possible intervention, making it an ideal 
medication adherence measurement.   
 
5.4 The influence of duration on ART, disclosure status, treatment supporter reminder and 
type of regimen on the effectiveness of SMS reminders on adherence to scheduled 
medication pick up appointments. 
 
Duration on ART: The mean duration of the study participants on ART was 3.6 years and this 
was fairly balanced  for the intervention and control arm of the study. The findings from this 
study suggests that duration on ART is not significantly associated with adherence to 
medication pick up appointments. However, the  bivariate model shows that 36% of the  patients 
who have been on ART for less than 1 year kept all medication appointments as compared to 
49% of patients  on ART for more  than 1 year. This infers that patients who have been on 
treatment for less than one year are less likely tohonour all medication pick up appointments as 
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compared to patients on ART for more than one year. Similarly, Kunutsor et al.(2010) did not 
report any significant asssociation between the duration on ART and adherence to appointments, 
however they noted that patients who are less than 2years on ART are less likely to honour all 
medication appointments.This indicates  that being less than 1  to 2years on ART  may be a risk 
factor for missing medication pick up appointments. Even though duration on treatment is not a 
predictor of adherence to appointments, it is worthy of noting that  patients who miss one or two 
visits within the first year after initiating treatment,  have an increased risk of mortality and lost 
to follow up (Brennan et al 2010). Furthermore non-adherence to clinic and medication pick up 
appointments very early after initiating ART, has been shown to reduce the overall effectiveness 
of treatment and result in poorer long term clinical outcomes in this group of patients (Park et 
al., 2006). Our results therefore suggest that in addition to SMS intervention for those patients 
willing to receive SMS reminders, other supportive measures such as early linkage to 
community or peer support  groups  must be considered for patients less than one year on ART. 
Treatment supporter reminder: A treatment supporter is anyone the patient chooses from 
amongst their family members, friends or workplace colleagues whose task is to accompany the 
patient to the clinic, provide support with daily adherence to ART, such as helping to pick up 
medications and reminding patients of appointments and taking medications on time. One of the 
social eligibility criteria for starting ART is that patients should ideally have a treatment 
supporter before they are initiated on ART. It is important to note that the guidelines state that 
patients should not be denied ART if they do not have a treatment supporter (MoHSS, 2014). It 
is therefore not a surprise that over 92% of the study participants reported having treatment 
supporters. The pre-intervention survey revealed that over 70% of study participants reported 
that their treatment supporter reminds them of their medication pick up appointments regularly, 
which is one of their roles as previously noted. Unexpectedly, the results from this study 
indicates that patients who were reminded of their appointment by treatment supporters were less 
likely to adhere to medication pick up appointment by about 11% than those who were not 
although this association was not statistically significant on either bivariate or multivariate 
analysis. Regrettably, we could not find any previous studies showing the impact of the role of 
treatment supporters on adherence to medication pick up or clinic appointments in a similar 
setting. We may however cautiously infer that the principle of habituation and diminishing 
response to frequent SMS reminders on adherence to medication noted above, may also apply to 
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repeated reminders of scheduled appointments by treatment supporters, to patients on ART. 
Additionally, it is likely that some HIV infected patients may find repeated reminders by 
supporters as overbearing and intrusive.  
Disclosure of HIV status: The result from the pre-intervention survey revealed that over 92% of 
the study participants reported that they disclosed their HIV status to a friend, family member or 
spouse. The high level of disclosure rate is not unexpected noting the equally high proportion of 
study participants that reported having a treatment supporter. This study reports that patients’ 
HIV disclosure status was not predictive of adherence to appointments based on the bivariate and 
multivariate regression analysis. Similarly, both the Namibian Antiretroviral Adherence Baseline 
Survey of 2012 and the Rwandan Antiretroviral Adherence survey of 2011 did not report a 
significant association between patients HIV disclosure status and adherence to medication pick 
up appointments. Generally, it is anticipated that patients who have disclosed their HIV status are 
more likely to be willing to receive SMS reminders without fear of stigmatisation. Whether 
perceived or actual, HIV related stigma still remains a formidable barrier to achieving optimal 
adherence to ART by HIV infected patients, in resource limited settings (Mills et al., 2006). 
Indeed previously 17% of patients on ART surveyed at the Swakopmund ART clinic reported 
work place related privacy issues as a reason for missing medication pick up appointments 
(Manhando & Ugburo, 2012). It is not unlikely that some patients may miss their clinic 
appointments because they do not want their employers to know they are receiving ART, for fear 
of stigma and discrimination in the workplace. The finding from this study suggests that SMS 
reminders may not be effective in patients that are employed and have not disclosed their status. 
It is encouraging to note that throughout the duration of this study, there was no report of study 
participants requesting to stop receiving SMS reminders, or expressing concern that their HIV 
status being disclosed inadvertently, as a result of the SMS reminders. 
Type of regimens: In general there are 6 first line regimens recommended in the Namibia ART 
guidelines. Of the 6 regimens only Tenofovir/Lamivudine/Efavirenz is a once daily regimen 
while the other 5 are twice daily regimens. It is worthy of note that before the  launch of the 
revised guidelines in January 2014, Tenofovir/Lamivudine/Nevirapine was the prefered first line 
regimen. This explains the  lower proportion of participants on the once daily regimen of 
Tenofovir/Lamivudine/Efavirenz,which at the time of our investigation,was then an alternate 
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first line regimen given to those who had a contraindication to Efavirenz. In this study there was 
no association between being on a once or twice daily regimen and adherence to medication 
pick up appointments. Review of the literature indicated sparse publication  on the association 
between the frequency of dosing and adherence to appointments, rather published studies on 
regimens compared pill burden or frequency of dosing and adherence to medication (Elul et al., 
2011;Tjituka et al., 2012;  Nachega et al., 2014). It is important to note that pill burden was not 
considered in this current study. 
 
5.5 The influence of socio-economic and demographic characteristics of patients on the 
effectiveness of SMS reminders on adherence to scheduled medication pick up 
appointments. 
 
Conclusions from previous studies on the influence of patients socio-economic and 
demographic characteristics on the  effectiveness of SMS reminders on adherence to  
appointments are conflicting and largely inconsistent. Eventhough forgetfulness has been cited 
as a major reason of missed appointment among patients on ART, evidence indicates that 
factors such as transport and distance from clinic, work related issues, unscheduled travelling 
and waiting time are some of the documented barriers of adherence to medication refill 
appointments as well as clinic visits (Brennan et al., 2010; Tjijuka et al., 2012; Manhando and 
Ugburo,  2010; Cole-Lewis, 2013).  
The findings from the current study indicate that the following socio-demographic and 
economic variables; age, gender, alcohol use, distancefrom the clinic, marital status and 
employment status are not significantly associated with honouring all medication pick up 
appointments. Likewise, the Namibian adherence baseline survey of 2012 did not report any 
significant association between age, gender, alcohol use, distance from the clinic, marital status,  
employment status and adherence to appointments. The patients socio-economic and 
demographic characteristics in relation to effectiveness of SMS reminders and adherence to 
appointments are worth noting. 
Gender: In the overall, there were slightly more males 203(52.3%) than females recuited into 
the study. this is consistent with the gender distribution in our setting based on the December 
2012 monthly report of the clinic, the   male pateints accounted  for  54%  of  adults on 
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treatment, It is worth noting that there were slightly more males (58.2%) in the intervention arm 
of the study. 
Marital status: In this study, the proportion of single and married statuses constituted over 70% 
of the reported marital status with the proportion of married  patients slightly higher in the 
intervention arm of the study. Vice versa the proportion of single patients was slightly higher in 
the control arm of the study. This indicates that randomisation is not a flawless procedure.  
Employment status: An unemployment rate of about 30% is reported by participants in this 
study. Interestingly, this is consistent with the official unemployment rate of 30% reported in the 
Namibia Population and Housing Census Indicators report of 2011 for Erongo region (Namibia 
2011 Population and Housing Census Indicators). The results from the bivariate model shows 
that a higher proportion of employed patients honoured all medication pick up appointment as 
compared to the unemployed, although we found the cumulative incidence ratio and risk 
difference statistically insignificant. It is probable that some of the unemployed patients may 
miss medication pickup appointments due to inability to afford transportation cost for those 
living far from the clinic.  
Alcohol use and adherence to appointments: The result from the current study reveals that 
28.6% of participants consume alcohol. Interestingly, in 2002, a study conducted by the Ministry 
of Health and Social Services reports that 56% of adults in Namibia consume alcohol with an 
average of 30 units/beer consumed in the previous week (MoHSS, 2002). Also, the level of 
alcohol consumption reported by patients in this study indicates that an average of 1, 7 and 2.3 
units of alcohol are consumed per day and weekends respectively. This result suggests that 
alcohol use among patients is recreational, considering the safe limits of 21 and 14 units of 
alcohol consumption per week for men and women respectively which was set by the Royal 
College Physician (Thomas et al., 2012). It is important to note that not abusing alcohol or 
refraining from alcohol abuse is one of the social eligibility criteria for starting patients on ART, 
consequently patients are continuously screened and counseled on alcohol abuse, this may have 
influenced the level of alcohol consumption in the study population as compared to higher levels 
reported in the general population. Furthermore, there was no significant association between 
consuming ≤ 1 unit of alcohol/day and ≤ 2 units of alcohol/weekend or > 1 unit of alcohol/day 
and > 2 units of alcohol/weekend and honouring all medication pick up appointments.  
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Age: The findings from this study did not show any significant association between age and 
keeping medication appointments. Even though Kunutsor et al. (2010) and Bofilla et al. (2006) 
reported that younger aged patients are more likely to honour schedule clinic appointments, 
Brennan et al. (2010) demonstrated older pateints are more likely to adhere to schedule 
appointments than younger patients. Naturally, we would have  expected a significant influence 
of the reminder among younger patients because they are more technologically disposed, 
however, older, employed patients with busy schedules  may be more inclined to forget 
appointments and therefore find SMS  reminders more supportive. 
Distance from health facility: In this study, we classified walk able distances between 0 – 5km 
as near to the clinic and 5 – 15km as far from the clinic. It is logical to expect more patients 
living near the health facility to adhere better to appointments as compared to living distant from 
the health facility. Surprisingly, the results from this study indicates otherwise, we found that 
44%of patients residing near the clinic honour all medication pick up appointment as compared 
to 47.2% of patients residing distant from the clinic. However, this association was not 
statistically significant in relative and absolute terms.  Interestingly, there is no data to suggest 
that distance to the health facility is predictive of adherence to appointments, in addition only 3% 
of respondents in the Namibian national adherence baseline survey of 2012 indicated difficulty 
in assessing health facility as a reason for missing appointment. 
5.6   SMS reminders and adherence to medications. 
The findings from this  study shows that motivational SMS reminders delivered two days prior to 
scheduled medication pick up appointment significantly influenced adherence to antiretroviral 
medication. In this study self-reporting and pill count was used to measure adherence and both 
results were compared. Beforehand, optimal adherence for pill count assessment  was defined  as  
≥ 95% adherence levels, while adherence levels <95%  was defined as as sub-optimal adherence. 
The differences noted in the results from adherence assessed by pill count and self-report was not 
unexpected because self-reported adherence is often  exaggerated (Simoni et al., 2006). 
Expectedly, in this study  a higher adherence levels were recorded from self report however, 
there is a fair correlation between the  CIR recorded from pill count 1.14 (95%CI:1.01-1.30) and 
self-reporting 1.18 (95%CI:1.07-1.31) as well as the risk difference. However, the association 
was not statistically significant at the multivariate logistic regresssion level for pill count. On the 
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other hand, the adjusted CIR  and RD indicates a statistically significant association between 
SMS reminder and adherence assessed via self-report. After removing  “ adherence to  
appointments” from  the backward stepwise regression model, the result shows a change in the 
adjusted CIR and  a significant association for  both self-reported and adherence assessed via pill 
count. It thus appears that adherence to appointments is acting as a partial  intermidiate variable 
between SMS reminder and adherence to medications, suggesting that  patients who recieved 
SMS reminder are more likely to keep appointments and in thesame vein,  are  more likely to be 
adherent to medications. In spite of this encouraging result, previous studies on the  effectiveness  
SMS reminders on  adherence to ART in Sub-saharan Africa has been  largely conflicting. 
Hitherto, only 2 studies both conducted in Kenya  reported that SMS reminders significantly 
improved adherence to ART (Lester et al., 2010; Pop-Ellechas et al., 2011). On the other hand, 
the  Cameroon Mobile Phone SMS (CAMPS) trial and a pilot study conducted in rural Sierra 
Leone reported that SMS reminders did not significantly  improve  adherence to ART 
(Mgbaugwu et al,. 2012 ; Kelly et al., 2012). The findings from these studies should be 
interpreted in the context of the study setting, duration of follow up and the content of  the SMS 
message.  
The CAMPS trial was an urban, single site randomised control trial in which a  one way non 
interactive weekly motivational SMS reminders were sent to treatment experienced patients in 
the intervention arm of the study and participants followed up for 3 months and 6 months. 
Adherence  was assessed by visual analogue scale (VAS), self-report and pharmacy refill data, 
with > 95%  adherence defined as optimal adherence. Mgbaugwu and colleagues (2012),  
concluded that SMS reminder did not result in significant improvement in adherence to ART. 
Likewise, Kelly and colleagues (2012) did not report significant improvement in adherence to 
ART, in a rural single site randomised control pilot trial in which a  non interactive SMS 
reminders were sent daily from the 2nd day prior to the appointment, while the control group 
only received weekly SMS reminders and thrice weekly community home visits in addition to 
standard care available to both groups. This study is limited by the inadequate sample size and a 
short follow up duration of 3 months. Contrary to findings from CAMPS trial and the rural Sierra 
Leone pilot trial, Lester and colleagues (2010) reported that patients that recieved a weekly 
interactive SMS reminders recorded a 19% improvement in adherence as compared to standard 
treatment without reminders. It is important to note that this was a multi centre trial of newly 
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initiating patients on ART which were followed up for 1 year without masking participants and 
clinic staff involved in data collection. Optimal adherence was defined as > 95%  adherence in 
the previous 30 days by self-report, interestingly SMS reminder was also associated with 
significant viral load suppression. Pop-Elleches and colleagues also reported that SMS reminders  
increased the proportion of participants achieving optimal adherence by approximately 11% as 
compared to no SMS reminders in  a rural setting. Moreover, Horvath et al. (2012) pooled the 
two Kenya trials in a meta analysis  and demonstrated that short SMS reminders significantly 
reduced missed apointment by  22% regardless of whether the reminder message was long or 
short at 48-52 weeks. Our result is fairly similar to the 11 – 19% improvement in adherence to 
ART in reported in the two SMS intervention studies conducted  in Kenya (Pop-Ellechas et al., 
2011; Lester et al., 2010).  
Sub analysis of the patients preference or need for reminder  shows that willingness to receive 
reminders is a potential effect modifier of SMS reminder and adherence to ART. 
Lastly, the result from the current study suggests that sending motivational reminders 2 days 
prior to scheduled medication pick up appointments produces fairly similar improvements in 
adherence to ART as weekly SMS reminders. This is worth considering in a resource constrained 
settings where more human and material resources may be required to scale SMS reminder. 
 
5.7 The influence of socio-economic and demographic characteristics of patients on the 
effectiveness  of SMS reminders on  adherence to  ART. 
 
In order to determine socio-economic and demographic variables that are independently 
associated with adherence to ART, all variables that were < 0.1 in the bivariate were 
incorporated in our multivariate model. This current study is suggesting patients employment 
status is a predictor of adherence to ART. In addition, younger aged patients < 35 years are less 
likely to adhere to ART although this association is not statistically significant. The results from 
this study did not demonstrate statistically significant differences between adherence to ART and 
the following independent variables; gender, duration on ART, alcohol consumption, distance 
from the clinic and  marital status. Conclusions from previous studies on the influence of patients 
socio-economic and demographic characteristics on adherence to ART has been conflicting.  
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Age: The results from the bivariate analysis shows that patients of younger age (less than 35 
years) are less likely to attain optimal adherence as compared to older patients by about 6 – 13% 
with a significant risk difference. However, the adjusted CIR indicates that age is not 
independently associated with achieving optimal adherence at the multivariate level for both 
measures of adherence. Similarly, age was not reported to be independently associated with 
adherence to ART in the Rwandan national baseline survey of 2010 (Elul et al., 2011).  On the 
other hand, Parietal et al. (2004), Williams et al. (2006) and Kunutsor et al. (2010) showed that 
younger age is independently associated with poor adherence. On the contrary Golin et al. (2002) 
and Mbaugbaw et al., (2012)  did not find age to be predictive of medication adherence. In the 
light of the outcome of this study, patients who are are less than 35 years of age and are willing 
to be reminded of their medication appointment may also be supported with other adherence 
improvement measures such as being linked to community support groups. 
Employment Status: The bivariate analysis indicates that,  patients who are employed are more 
likely to attain optimal adherence by about 19 – 26% as compared to the unemployed. In terms 
of risk difference, the patients who are unemployed have a 14 %  risk of not acheiving optimal 
adherence. The adjusted CIR also shows a significant association between employment status 
and medication adherence. This result therefore suggests that the patients employment status is 
an independent predictor of medication adherence. However results from the Namibia national 
adherence baseline survey of 2012 did not find any association between  employment status and  
medication adherence, Tjijuka et al.,(2012), proposed that government effort to make ART 
available and accessible to patients without payment regardless of social status might explain the 
insignificant association between socio economic and demographic factors and  adherence to 
ART.  We are cautious to suggest that SMS reminders probably influenced adherence among 
patients that are employed in this study, even though it is also likely that patients who are 
employed may be more motivated to adhere to ART and less likely to forget taking their 
medicines as prescribed. 
 The conflicting conclusions from previous studies stated above may  be due to the  complex  
interplay of several factors and because behaviour change sits right in the pathway between the 
intervention (SMS reminder) and health outcome (adherence), a complex interaction of 
psychosocial and demographic variables and adherence has been proposed (WHO. 2003). 
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Williams et al. (2006) and Golin et al. (2002) reported substance abuse and depression to be 
predictors of non adherence to ART, in addition, Parietal et al., (2004). found depression to be  
independently associated with virological failure. Furthermore, Mills et al. (2006) and Nelson 
(2012) reported that high level of patient motivation and positive experiences are key facilitators 
of adherence to ART. These variables were not considered and tested in this study due to logistic 
constraints. 
 
5.8 The association between SMS reminders and the number of missed days. 
 
The SMS reminder significantly reduced the duration of the number of  missed days between 
scheduled medication appointment date and date of visit as compared to  participants  that did 
not receive reminders. The number of days late is a pointer to non adherence to  ART because 
study participants were given about  enough medicines to last untill the next appointment date. 
Studies have demonstrated the association between  treatment interruption of 1- 3 days  and 
virological failure. Brenan et al. (2010) showed a significant increase in viroligical failure and 
mortality amoung patients who missed appointment for more than 3 days. In thesame vein 
patients that have experienced one late pick up or ≥ 20 % late pick ups were found to be 
significantly associated with virological failure at 12 months after initiation of ART. (MoHSS 
2010). The number of days that elapsed between a missed visit and the next visit is critical, for 
the reason that as the number of days late increased, the occurrence of new AIDs definning 
illnesses and death increases significantly (Park et al., 2007). The mean difference between 
patients that recieved the SMS reminders and those that did not recieve the SMS reminders was 
4.4 days during the four consecutive ARV refill appointments. When the number of days late is > 
30 days, the hazard ratio inceased significantly by a factor of 5 (Park et al., 2007). In a resource 
limited setting, sending SMS reminders have the potential of reducing the number of late days, 
unlike  phone calls, messages could be saved on the phone especially when phone is not shared 
as a continuos reminder and in situations where privacy and confidentiality of patients is 
compromised the message could be deleted. 
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5.9 Study limitations  
 
Results from this study are based on the premise that patients who fail to adhere at short term are 
much less likely to adhere in the long term. However it is acknowledged that those who adhere in 
the short term might not adhere in the long term and a longer follow up period is desirable in 
order to assess adherence in the long term. it is anticipated that confounding variables will be 
balanced based on the RCT study design adopted for this investigation, however our failure to 
test effectiveness of SMS reminders influence on  psychosocial variables such as depression, 
substance abuse, social support, level of education, co-morbidities, use of other reminders such 
as alarm devices, and community support program is acknowledged as a limitation in this study.  
      In this study adherence to medication by a 3- day self-report and by pill count which are both 
fallible methods of assessing adherence. In addition, pill count was only done for one component 
of the regimen in cases where we have two medicines making up the regimen. We assume 
patients adhere equally to both medicines noting that this may not always be the case. However, 
research assistants could not ascertain whether participants brought all pills for counting at the 
commencement of the study. As a result of logistical and cost limits we could not validate 
adherence by viral suppression which is a more objective measure of adherence and a superior 
means of assessing HIV treatment outcome.  
The occurrence of contamination was not envisaged, and we could not check if any individual in 
the control group had a SMS reminder passed on to them by those in the intervention group. 
However even if this did occur it would only have influenced the results if those control subjects 
who  received these passed on SMSs had the same appointment date as the intervention 
participants who passed them on. In the same vein, we did not check if participants utilized other 
types of reminders such as alarms, which could have influenced adherence. Also we could not 
ascertain whether the SMSs were either received or read by participants in the intervention group 
in order to evaluate to what extent the SMS reminder actually influenced any behavioral changes 
that brought about differences in keeping appointments and adherence between the two groups. 
We could only confirm to whom SMSs were sent and that they were delivered. 
 Data and analysis on cost effectiveness of the intervention could not be done due to time and 
logistical constraints, therefore the sustainability of this intervention could not be determined.  
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The monthly adherence counseling session given to all participants was likely to exaggerate 
adherence in both arms of the study, as compared to other patients not exposed to monthly 
adherence counseling therefore this need to be noted when interpreting the results from this 
study. 
Only those participants that were willing or preferred to be reminded of their appointments 
should have been included in this study, in essence the result of the study would only have been 
generalized to only about 60% of patients who were willing to receive reminders, our result 
shows that the SMS reminders is more effective among patients who were willing to be 
reminded. In essence we were able to assess unsolicited SMS reminders and our results can be 
generalized to all patients in similar settings.  
Short message service confidentiality was not an issue in this study, throughout the duration of 
the study, none of the participants in the intervention group objected to reminder messages, 
however shared usage of cell phones  might  compromise confidentiality. 
      Aside from the limitations of this study, the scientific rigor and the very low proportion of lost to 
follow up during the study period is worth noting as its strength. 
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                                               Chapter 6 
                                Conclusion and Recommendations 
 
6.1 Conclusion 
        
       Short motivational SMS reminders sent two days before scheduled medication pick up 
appointments were found to be effective in improving adherence to scheduled medication refill 
appointments.  SMS reminders increased the likelihood of keeping scheduled appointment by 
22% and SMS reminders significantly reduced the number of days late for medication refill 
appointments, thereby reducing the risk of patients interrupting treatment which may lead to 
development of resistance, treatment failure and switching patients to more expensive second 
line antiretroviral medication. Similarly, although to lesser extent, SMS reminders improved 
antiretroviral adherence. The patients that received SMS reminders are more likely to attain 
optimal adherence by about 14 – 18%. Those who preferred to receive SMS reminders were 
more likely to benefit from the SMS reminder, but this result was not statistically significant. To 
the best of our knowledge this is the first reported trial on SMS reminders and adherence to ART 
medication and adherence to ART refill medication appointments in Namibia. However, more 
research is needed in evaluating the impact of the message content and timing of the message on 
the effectiveness of SMS reminders.  
Since adherence to medication appointments showed a strong association with adherence to ART 
medication, the use of medication refill appointments monitoring, as an easy to do proxy 
measure of adherence to medication, it is feasible and especially useful in a resource constrained 
setting. Patients that have been on ART for less than one year and those whose  treatment 
supporters  reminded them of their appointments, were paradoxically significantly less likely to 
adhere to medication refill appointments. Being employed was significantly associated with 
attaining optimal adherence to antiretroviral medication.There were no other significant 
associations between the patients socio-economic and demographic characteristics and adherence 
to scheduled medication pick up appointments, or to adherence to medication.  
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6.2 Recommendations 
 
The Namibian Ministry of Health should consider rolling out the same or a similar SMS 
reminder to patients on ART (and by implication any other chronic medication) and especially to 
patients who indicate willingness to receive a SMS reminder.  
Late and missed appointments are easy to measure and therefore it can be used as a proxy 
measure for adherence to medication. The practice of treatment supporters reminding patients to 
take their medication and to keep their appointments should be thoroughly reviewed, as it 
appears to be unhelpful. 
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                                                                Appendix A 
 
                       Interviewers Name__________________________ 
 
                    SMS REMINDER AND CLINIC APPOINTMENT STUDY 
 STUDY NO:   SN-Ib OR 2r                                   Coding Column 
 
       Blue Marble                                                                               1                                                                                  
       Red Marble                                                                                 2 
 
 
 
      2. DURATION ON TREATMENT:  In Years and months  
 
      3.  REGIMENS 
     NRTI 
     AZT based             1 
     TDF based            2 
     D4T based            3 
     NNRTI 
      NVP based            1 
      EFV based            2 
      PI’s 
     YES                       1 
      NO                        2 
 
 
 
 
     4. AGE:       AT LAST BIRTHDAY (YEARS) 
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    5. SEX 
        MALE                                                                                                       1 
        FEMALE                                                                                                   2 
 
 
    6. MARITAL STATUS 
    SINGLE                                                                                                    1 
    MARRIED                                                                                                2 
    WIDOWED                                                                                               3 
    DIVORCED/SEPARATED                                                                      4 
    CO-HABITING                                                                                         5 
 
    7. HAVE YOU INFORMED YOUR PARTNER/RELATIVE/ FRIEND OF YOUR HIV 
STATUS 
    YES                   1 
     NO                    2 
 
 
     8.LOCATION (Assessing Distance From Clinic) 
   WHERE DO YOU LIVE 
   TAMARISKIA                                                                                                  1 
   MONDESA                                                                                                       2 
   TULINAWA                                                                                                      3 
    DRC                                                                                                                    4 
    VINETA                                                                                                             5 
    TOWN                                                                                                                6 
     NONIDAS                                                                                                         7 
     OTHERS..(List).....................................................................................                                                                       
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      9. EMPLOYED 
    YES       I 
    NO         2 
 
     IF YES TO  8. 
 
       10. TYPE OF EMPLOYMENT 
              GOVERNMENT             1 
              PRIVATE COMPANY   2 
              FARM                              3 
               SELF EMPLOYED         4 
 
        11. WHAT IS YOUR MONTHLY INCOME N$ 
 
        12.  ALCOHOL 
               DO YOU DRINK ALCOHOL 
               YES                               1 
               NO                                 2 
 
         13. IF YES TO 10. 
               HOW MAY UNITS OF   BEER/ WINE/ SPIRIT/ LOCAL BREW 
                DO YOU DRINK ON WEEKDAYS                   AND WEEKENDS                         
 
 
         14.  DO YOU HAVE A TREAMENT SUPPORTER 
                    YES          1 
                     NO            2 
 
         15.  IF ANSWER TO 12 IS YES  
                 HOW OFTEN DOES YOUR TREATMENT SUPPORTER REMIND YOU OF     
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           YOUR CLINIC APPOINTMENT 
 
                  ALWAYS                1 
                 OCCASIONALY     2 
                 NEVER                     3 
 
          16.  DO YOU WANT TO BE REMINDED OF YOUR CLINIC  APPOINTMENT 
 
        YES                      1 
        NO                        2 
 
           17.  HOW DO YOU PREFER TO BE REMINDED 
 
      THROUGH CALLS     1 
       SMS                             2 
      CALLS AND SMS       3  
 
 
            18. DO YOU HAVE A CELLPHONE? 
             YES                        1 
              NO                         2 
 
            19. IF YES TO 18  DO YOU SHARE YOUR PHONE WITH YOUR PARTNER/FRIENDS 
             YES                         1 
              NO                          2 
           20. IF NO TO 18 DO YOU HAVE DAILY ACCESS TO A  CELLPHONE 
 
           21.  WHAT TIME OF THE DAY WILL YOU PREFER TO RECEIVE A REMINDER 
           MORNING               1 
            AFTERNOON          2 
       EVENING                 3 
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       ANYTIME                4 
 
        22. How long before your appointment would you like to receive your reminder 
              1 day                     1 
              2 days                    2 
              3 days                    3 
              4 days                    4 
              5 days                    5 
 
           Signature of Interviewer______________________ 
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                                                                    APPENDIX B 
                          
                                     SMS REMINDERS AND CLINIC APPOINTMENT STUDY 
                                            PARTICIPANTS APPOINTMENT LOG SHEET 
 
     STUDY NO: ___________________________                
 
   Scheduled 
Appointment 
Date 
A 
Date of 
Visit 
 
B 
Missed=1 
On time=0 
 
C 
No of 
Days 
Missed 
D 
 
Pill Count 
5      No of doses given- left over pillX100=% adherence 
No of  doses  required to be taken in the time period 
 
How many doses did 
you miss in the 
last 3 days 
(Self report) 
      
      
      
      
Total      
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                                                                          Appendix C 
                      UNIVERSITY OF THE WESTERN CAPE 
                       School of Public Health 
 
                Private Bag X17 ● BELLVILLE ● 7535 ● South Africa 
                          Tel: 021- 959 2809, Fax: 021- 959 2872 
Participant Information Sheet 
     July 2012. 
     Dear Participant, 
     Thank you for your willingness and interest in this research. What follows is an explanation of 
the research project and an outline of your potential involvement. 
     The research is being conducted for a thesis, which is a requirement for the Masters in Public 
Health which I am completing at the University of the Western Cape. If there is anything you do 
not understand or are unclear about, please feel free to ask me. My contact details and those of 
my supervisor are attached. 
      Title of research         
      An evaluation of adherence to scheduled appointments among adults on highly active 
antiretrovirals at the Swakopmund ART Clinic 
 
Purpose of the study 
      The purpose of the study is to improve adherence to antiretrovirals, thereby improving health 
outcomes. It is hoped that this research will guide policy makers in making policies that will 
improve adherence to scheduled ARV pick up appointments. 
 
      Description of the study and your involvement 
      This study will require interviews which will not last more than 30 minutes. Information 
about your age, socioeconomic and demographic status will be asked. 
 
Confidentiality 
       Your name and records of your participation will be kept confidential at all times, including a 
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signed consent form, which we will need from you, should you agree to participate. All 
documents pertaining to you and the information you provide will be destroyed after the research 
is completed. 
 
      Voluntary participation and withdrawal 
       Your participation in this research is entirely voluntary and  there  is no adverse consequence if 
you decide not to participate. If you choose to participate, you may stop at any time. You may 
also choose not to answer any questions that are asked in this study, if there is anything you may 
prefer not to discuss. 
Benefits and cost 
      You may not get any direct benefit from this study, however the information we get from 
participants in this study may help in guiding policy makers and program managers on how best 
to  support  patients in adhering to care and treatment. Other than the 30 minutes or less that you 
will be required to spend for the interview, there are no other costs for participating in this study. 
 Informed consent 
      Your signed consent to participate in this study is required before I proceed to interview you. I 
have included the consent form with this information sheet so that you will be able to review the 
consent form and then decide whether you would like to participate in this study or not. 
      Enquiries  
       Should you have further enquiries or wish to know more, I can be contacted as follows. 
       Emmanuel Ugburo 
       Student Number: 30003234 
       Cell Phone: 0813416274  Work Phone: 061- 2032348 
        e-mail :deleman2010@gmail.com 
        I am accountable to Dr. Gavin Reagon, my supervisor at UWC, his contact details are  
        School of Public Health 
        University of the Western Cape 
        Private Bag x17. Bellville  
        021-9593563 
        Fax: 021-9592872 
        Email greagon@uwc.ac.za 
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Appendix D 
UNIVERSITY OF THE WESTERN CAPE 
                                                            School of Public Health 
 
Private Bag X17 ● BELLVILLE ● 7535 ● South Africa 
                  Tel: 021- 959 2809, Fax: 021- 959 2872 
          TITLE 
           An evaluation of  adherence to scheduled appointments among adults on antiretroviral at the   
Swakopmund State Hospital ART  Clinic. 
 
       ---------------------------------------------------------------------------------------------------------------  
       I have read the information about this research study on the Participant Information Sheet or it has been read to me 
and  I have had the opportunity to ask questions and my questions have been answered to my satisfaction . 
       I consent to voluntarily participate in this research. I understand that there are no adverse consequences if I do not 
participate and that I have the right to end the interview at any time andto choose not to answer particular questions 
I’m asked in the study. 
       My signature indicates my willingness to participate in this research. 
 
      ----------------------------------------------------------------------    
      Participant Name (Printed) 
      -----------------------------------                             ------------------------------------------------ 
      Participant Signature                            Consent Date 
 
       ------------------------------------------------------------------------ 
       Researcher Conducting Informed Consent   (Printed) 
 
       ---------------------------------------------------------------              ----------------------------------------              
    Signature of Researcher                                                                          Date    
 
 
 
 
 
 
 
 
 
 
 
96 
                                                                                   Appendix E 
 Definition of Terms  
      Scheduled clinic appointment  
      Kunutsor (2010) defines schedule clinic appointments as regular appointments e.g monthly   
appointments for medication pickups. In this study, schedule appointments are defined as 
scheduled ARV refill appointments whichare monthly. This date is communicated to the patient 
before leaving the pharmacy and noted legibly on the patients health passport which is normally 
taken home, this is a very important step in ensuring adherence to scheduled appointments as 
noted by Pinsker et al (1995). The medical or physician only appointments are scheduled in line 
with the national ART guideline and by the clinical judgment of clinicians. It is worth noting that 
the two appointments may coincide, for example the physician may give a 3 – 6 months follow 
up date to a stable patient, while the pharmacy schedules monthly appointments, the third and the 
last of which coincides with the physician’s appointments 
     Lost to Follow Up (LTFU) 
     These are patients that cannot be traced after concerted attempts to do so, however operationally 
in our setting for the purpose of adherence monitoring, a patient is said to be LTFU if he/she fail 
to turn up 90 days after the last scheduled appointment for ARV pickup and if he /she was not 
known to have transferred to another treatment centre, stopped therapy without restarting or died. 
(Hong et al., 2010; Ugburo and Ongeri, 2011) 
     Missed appointment: 
     In this study, two definitions for missed appointment will be adopted. A strict definition of 
missed appointment is failure to turn up on the day he/she is scheduled for ARV refill, without 
prior rebooking. While a less strict definition is where patients fail to turn up within 2 days of 
scheduled ARV refill appointment without prior rebooking.  In the event of rebooking a new 
follow up date will be given to the patient. The rate of missed appointments is the ratio of the 
number of  times a patient fails to turn up for  pre-arranged ARV refills appointments over  the 
total  number of scheduled appointments (Mugavero et al., 2010). The first definition is those 
who failed to turn-up on scheduled day. While the second category are those who turned up 
within 2 days of their scheduled appointment. 
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                                                                   Appendix F 
Oshiwambo Translation 
     Sepetemba 2012 
 
     Osikola Yuundjolo wele wopa shigwana 
     Uuyelele wanakukutha omblinga 
     Nakukutha ombinga omusimanekwa 
 
ndapandula uumene shiwuna Ehalo neyi tulemo Iyo kukutha ombinga mekongo iyomayu yelele 
ndika.Shi shalandulago                                 
mpaka; Ehokolo nkene tashivuliko awuka kuthe unyelele. Ekongo iyo mauyelele ndika olili onga 
oshitopolwa sheyi longo iyonzapo yo mbanda (master in Public Health), ndjoka  ngame teningi 
ko shiputudhiyo shopombandasha Western Cape. Ngele otapukallaka ompumber yandje no 
yomukuluntugwa ndge yili ondeyigandja maka 
 
       Edhina Iyo Shilongwa 
             Eko       nakono nkene aavu haya gwathipa omasiku goka galukila ko kapangelo kepango iyo      
            mbuto kalmo Swakopmund. 
 
        Elalaka Iyo Shilongwa Shika  
           Ela   kukano okahumitha komehonkene aavu yena kugalukila kokapangelo, no kumawa paleka     
undjolowere waantu. 
 
 
 
       Edhina Iyanakupala__________________________ 
 
 
 
 
 
 
 
 
 
 
98 
          SMS REMINDER AND CLINIC APPOINTMENT STUDY 
STUDY NO :   SN-Ib OR 2r                                   Coding Column 
 
   Blue Marble                                                                               1                                                                                  
   Red Marble                                                                                 2 
 
      2. ETHIMBO IYEPANGO : Liti momvula noo mwedhi  
 
      3.  ONGUNDU YOMITI 
           NRTI 
            AZT based             1 
            TDF  based            2 
             D4T  based            3 
            NNRTI 
            NVP based            1 
            EFV  based            2 
            PI’s 
            YES                       1 
             NO                        2 
 
4. OOMVULA:       PEVALO IYAPITI 
 
        5. SEX 
             MALE                                                                                                       1 
             FEMALE                                                                                                   2 
 
 6. MARITAL STATUS 
           INO HOMBOLA                                                                                                     1 
             OWAHOMBOLWA                                                                                                2 
             OMUFIYELKADI                                                                                                  3 
             OKWAHENGANA                                                                                                 4 
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             OKWOOTEKA                                                                                                        5 
 
         7. OWALOMBAELE OMUHOLIKE GWOYE MPA WATHINKA NOMBUTO YO 
           EE                   1 
           AYE                2 
 
 
          8. EHALA   
          (OHOZI PENI) 
           TAMARISKIA                                                                                                 1 
           MONDESA                                                                                                       2 
           TULINAWA                                                                                                      3 
            DRC                                                                                                                    4 
            VINETA                                                                                                             5 
            TOWN                                                                                                                6 
            NONIDAS                                                                                                         7 
            OTHERS..(List).....................................................................................                                                                       
 
         9. OHOLONGO 
              EE       I 
              AYE    2 
     IF YES TO  8. 
 
     10. OHOLONGO IILONGO YOLUDHI LUNIPO 
          MEPANGELO                                                 1 
          EHANGANO IYOPAWUMUWENE             2 
          UUNAMAPYA NUUNIIMUNA                     3 
          HWIILONGELE                                                4 
 
      11. IIYEMO YOYE YOKOMWEDHI N$ 
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      12.  LIKODWITHA 
       OHONU OMALOVU 
         EE                               1 
        AYE                             2 
 
        13. IF YES TO 10. 
        OHONU SHITHIKEPE MONASIKU GOSHIKE 
        MEHULILO SHIWIKE 
 
 
        14.  OWUNA OMUKWATHI GWEPANGO 
         EE                1 
         AYE            2 
 
        15.  IF ANSWER TO 14 IS YES  
               OMUKWATHI GWOYE OHEKUDHIMBULILUKITHA LUNGAPI    
 
                 ALUHE                                                          1 
                 OKATHIMBO NOKATHIMBO                  2 
I               HADHIMBULUKITHANDJE                     3 
 
          16.  OWAPUBWA KUKALA HODHIMBALUKIFERA ESIKU NDI WUNA OKUSHUPA  
 
                         EE                      1 
                         AYE                   2 
 
          17. OWAHAKA KUDHIMBULUKITWA NOMAKALOGUNI 
                 OKUDHENGELWA ONGODHI                                 1 
                  OKATUMWALAKA OKAHUPI                                 2 
                  ONGODHI NOKATUMVWALAKA OKATTIPI       3  
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        18. OWUNA ONGODHI YOMEKWAMO? 
                       EE                        1 
                       AYE                    2 
 
        19. NGELE EE KU 18, O HO GANDJA ONGODHI YOYE KAAKOLITE YEYE 
                       EE                         1 
                        AYE                     2 
        20. NGELE AAYE KU 18 , OHO MONO ONGODHI YO KU LONGIDHA 
 
        21.  OTOPUMBWA OKUDHIMBULIKITWA PANGODHI ETHIMBO ……. 
                   ONGULA               1 
                   OMUTENYA         2 
                   KONGULOHI        3 
                   KEHETHIMOBO   4 
 
        22. OWAHALA WUDHIMBULIKITWE KUNA OMASIKU GANGAPI, KESIKU 
IYOKUYAKO KAPANGELO 
                 EESIKE IIMWE                     1 
                 OMASIKU GAALI                2 
                 OMASIKU GATATU             3 
                 OMASIKU GANE                  4 
             OMASIKU GATANO             5 
  
             Signature of Interviewer______________________ 
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                                                                     Appendix G 
Afrikaans Translation 
 
Liewe deelnemer, 
Dankie vir jou bereidwilligheid en belangstelling in hierdie navorsing.Wat volgs is ‘n 
verduideliking van die navorsingsprojek en ‘n uiteensetting van jou moontlike betrokkenheid Die 
navorsing word uitgevoer vir ‘n tesis,wat ‘n vereiste vir die Magister in anenigiets is wat jy nie 
verstaan nie of onseker is oor,voel asseblief vry om my te kontak.My kontakbesonderhede en die 
van my toesighouer is aangeheg. 
Titel van navorsing 
‘N evaluering van Voldoening aan Geskeduleerde Aanstellings onder volwassenes op besonder 
aktiewe anti-retrovirale middels by die Swakopmund ART Clinic. 
Doel van die studie 
Die doel van dei studie is om die nakoming van antiretrovirale middels te verbeter en sodoende 
die verbetering van die gesondheid uitkomste.Daar word gehoop dat hierdie navorsing 
beleidmakers sal lei in die maak van beleid wat sal verbeter nakoming geskeduleer ARV optel 
aanstellings. 
Beskrywing van die studie jou betrokkenheid 
Hierdie studie sal vereis onderhoude wat nie meer as 30 minute duur. Inligting oor jou 
oudeerdom, sosio-ekonomiese en demografiese status sal gevra word. 
. 
Vertroulikheid 
 Jou naam en rekords van jou deelname vertroulik gehou sal word te alle tye, met inbegrip van’n 
getekende toestemming vorm, wat ons van u nodig sal he, moet jy 
saamstem om deel te neem. Alle dokumente met betrekking tot jou en die inligting wat u 
veerskaf sal vernietig word na die navorsing voltooi is 
Vrywillige deelname en onttrekking 
U deelname is hierdie navorsing is heeltemal vrywilling,en daar is geen nadelige gevolge,as jy 
besluit om nie deel te neem.As jy kies om deel te neem,kan jy op enige tyd stop.Jy kan ook kies 
om nie enige vrae wat gevra word in hierdie studie te beantwoord nie,daar iets is wat jy verkies 
om nie te bespreek nie. 
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Voordele en koste 
Jy kan nie enige direkte voordeel uit hierdie studie,maar die inligting wat ons kry van die 
deelnemers in hierdie studie kan help in die begeleiding van beleidmakers en program 
bestuurders op die beste manier om pasiente te ondersteun in die voedoening aan sorg en 
behandeling.Anders as 30 minute of minder wat jy sal verwag word om te spandeer vir die 
onderhoud,daar is geen ander koste vir deelname in hierdie studie. 
Ingeligte toestemming 
U getekende toestemming om deel te neem in hierdie studie word vereis voordat ek voortgaan 
om ‘n onderhoud te voer met.Ek het die toestemming van met hierdie inligtingstuk ingesluit 
sodat jy in staat sal wees om die toestemming vorm te hersien en besluit dan of jy wil om deel te 
neem in hierdie studie of nie. 
 
 
Navrae 
Indien u verdere navrae of wil meer weet,kan ek gekontak word soos volg. 
Emmnuel ugburo 
Student nommer:30003234 
Selfoon:0813416274 
Werk foon:061-2032348 
e-pos:deleman2010@gmail.com 
Ek is verantwoording aan Dr Gavin Reagon,my toesighouer by UWC,sy kontakbesonderhede is 
die skool van Openbare Gesondheid. 
University van Die Weste Kaap 
Privaat Sak x17.Bellville 
021-9593563 
Fax:021-9592872 
e-pos:greagon@uwc.ac.za 
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ONDERHOUD’S NAAM; 
BOODSKAAP ONTHOU EN KLINIEK AFSPRAAK STUDIE. 
1. STUDIE NOMMER; SN-1B or 2P 
Blue Marble                                                                   1 
Pink Marble                                                                    2 
 
2 VOORTDURING AAN BEHANDELING; in yare en maande. 
3     LEEFWYSE,REGIMENT 
NRTI 
AZT based                  1 
TDF based                    2 
D4T based                 3 
NNRTI 
NVP based                 1 
EFV based                 2 
PI’s 
Yes                              1 
No                              2 
             4 OUDERDOM; 
5 GESLAG;  
MANSMENS           1 
 VROUMENS                 2 
6  
     ONGETROUD                                                                     1 
            GETROUD                                                                         2                       
            WEDUWEE                                                                       3 
            GESKEI                                                                             4 
           GEWOONTE/ BEROEPSDRAG                                        5 
 
 
7.HET JY JOU MAAT,FAMILY OF IMAAND LAAT WEET VAN DIE SIEKTE. 
YA.                                                                                                             1 
NEE.                                                                                                            2 
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8.LOCASIE? 
WAAR WOON U? 
Tamariskia                                                                                                1 
Mondesa                                                                                                   2 
Tulinawa                                                                                                    3 
DRC                                                                                                            4 
Vineta                                                                                                         5 
Town                                                                                                           6 
Nonidas                                                                                                       7 
Others............................................................................................... 
 
9.WERK U? 
YA                                                                                                                  1 
NEE                                                                                                                2 
If Ya to 9. 
 
10.WATTER SOORT WERK DOEN U? 
STAD                                   1   
PRIVAAT                           2 
PLAAS.                                3  
EIE WERK.                         4                                                                                                   
 
11. WAT IS U MAANSLIKE INCOMSTE N$? 
 
12. DRANK. 
 DRINK U 
       YA                                      1 
 NEE                                     2 
 
13. HOEVEEL MEETEENHEID VAN DRANK,WYN OF LOKAAL BEER VAT U? 
A. DRINK U WEEKSDAE EN IN DIE NAWEEK. 
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14. HET U BEHANDELING HULP ONDERHOUD? 
 YA                                   1 
 NEE                               2 
 
15. HOEVEEL KEER SE JOU ONDERHOUD VIR JOU OM KLINIEK TOE TE GAAN 
VIR AFSPRAAK? 
ALTYD                            1 
SOMS                             2 
NOOIT                            3. 
16. WILL JY GE LAAT ONTHOU WORD AAN JOU AFSPRAAK OM KLINIEK TOE TE 
GAAN? 
YA                                  1 
 NEE                             2 
 
17. HOE WILL U GE LAAT ONTHOU WORD? 
 DEUR TETEFOON           1 
BOOBSKAAP                    2 
 ALTWEE                           3. 
 
18. HET U ‘N TETEFOON? 
YA                                   1 
NEE                                     2 
 
19.DEEL U,U FOON MET VRIENDE,MAATS OF FAMILIE? 
YA                                       1 
NEE                                    2 
 
 
20. IS U ALTYD BESKIKBAAR OP JOU FOON? 
YA                                   1 
NEE                                       2 
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21.HOE LAAT WILL U GE LAAT ONTHOU WORD? 
OGGEND                             1 
NAMIDDAG                       2 
AAND TYD                              3 
ENIGE TYD                              4 
 
22. HOE LANG VOOR JOU AFSPRAAK WILL U GE LAAT ONTHOU WORD? 
A DAG                                       1  
TWEE DAE                              2  
DRIE DAE                                3 
VIER DAE                                4 
VYF DAE                                  5. 
 
              Signature of Interviewer______________________ 
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                                                                     Appendix H 
Consolidated Standards for Reporting Trials (CONSORT) Checklist 
Title and Abstract 
1a. Title  
The Title does not identify this study as a randomised trial.  
1b. Abstract 
The abstract is presented as a structured summary consisting of trial design, methods, results, and 
conclusions. 
Introduction 
2a. Background 
Scientific background and rationale of the study covered in the introduction section. 
2b. Objectives 
Specific objectives were clearly listed. 
Methods 
3a. Trial Design 
Trial design well described  
3b. Changes to trial design 
There was no change in the trial design as approved in the protocol. 
4a. Participants 
Eligibility and exclusion criteria for participants pre-determined. 
4b. Study settings 
Study setting and location where the data were collected adequately described. 
5. Interventions  
  SMS reminder sent 2 days before scheduled ARV pick up appointment was the only 
intervention 
 
 
 
 
 
109 
6a. Outcomes  
 Pre-specified primary and secondary outcome measures were defined, including how and when 
they were assessed 
6b. Changes to outcomes  
No changes to trial outcomes after the trial commenced 
7a. Sample size  
     Sample size was calculated based on stated assumptions at 95% significance level and power 
of 80%, transfer out and lost to follow up were also considered in determining the sample size.  
7b. Interim analyses and stopping guidelines 
Not relevant to this study 
8a. Randomisation  
Method used to generate the random allocation sequence was explained 
8b. Randomisation:Type 
Type of randomization covered in detail 
9. Randomisation: allocation concealment mechanism  
 Allocation and concealment mechanism was described. 
10. Randomisation: implementation 
Randomisation implementation described in detail 
11a. Blinding  
Study participants, baseline data collectors, care providers assessing outcomes were all blinded 
to allocation of participants to groups. The chief researcher and the assistants that sent the SMS 
reminders were unblinded. 
11b. Similarity of interventions  
Not applicable, only one intervention 
12a. Statistical methods  
       An intention to treat principle was adopted in our analysis, this entails that all participants were 
analyzed based on the initial arm of the study they were randomized and grouped into, 
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irrespective of whether they dropped out or switched group.  The proportion of study participants 
who missed appointments were determined, the cumulative incidence ratio (CIR) and risk 
difference (RD) were also determined. The statistical significance was determined using the 95% 
confidence interval.  
12b. Additional analyses  
Methods for additional analyses, such as subgroup analyses and adjusted analyses was presented 
Results 
13a. Participant Flow  
For each group, the numbers of participants who were randomly assigned, received intervention, 
and were analysed for the primary outcome 
13b. Losses and exclusions  
Losses and exclusions covered in the sample realisation chart.  
14a. Recruitment  
Participants were recruited until the sample size was attained, the number of follow-ups was 
specified in the protocol. 
14b. Reason for stopped trial  
Not applicable 
15. Baseline Data 
A table showing baseline demographic and clinical characteristics for each group was presented 
as simple proportion and for continuous variable the mean, standard deviation and interquartile 
range was presented. 
16. Numbers analysed  
An intention to treat analysis approach adopted in this study and the number of participants 
(denominator) was included in each analysis. 
17a. Outcomes and estimation  
For each primary and secondary outcome, results for each group, and the estimated effect size 
and its precision at 95% confidence interval were presented.  
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17b. Binary outcomes 
Results of binary outcomes presented in terms of both absolute (Risk difference) and relative 
effect (Cumulative Incidence Rate). 
18.  Ancillary analyses  
 No exploratory analysis was conducted in this trial, primary and secondary analysis were as pre-
specified in the protocol. 
19. Harms 
 The potential for inadvertent status disclosure of confidentiality was discussed, in addition the 
number of participants that dropped out and lost to follow up covered in the results section. 
Discussion 
20. Limitations 
Study limitations, addressed sources of potential bias. 
21. Generalisability  
Adequate information on the eligibility criteria, study setting, definition of outcomes, the 
outcomes assessed, delivery and type of intervention, in this regard the result from this study 
could be generalised to other ART clinics in urban centres in Namibia. 
 22. Interpretation 
The results from this study were well linked with existing literature. 
Other information 
23. Registration 
Not registered, study is a mini-thesis submitted in partial fulfillment of the requirements for the 
degree of Master of Public Health, in the School of Public Health, University of the Western 
Cape 
24. Protocol 
The full trial protocol can be assessed from the ethics committee of the School of Public Health, 
University of the Western Cape. 
25. Funding  
This study was exclusively funded by the chief researcher. 
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